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Abstract 
Microfluidic Selection and Applications of Aptamers 
John P. Hilton 
 
BioMEMS technology has the potential to increase the efficiency of conventional 
biological and medical protocols, by reducing their consumption of time and resources. 
Through more efficient surface-based chemical reactions and automation of tedious 
manual processes, orders of magnitude increases in efficiency across a number of metrics 
can be achieved by shifting conventional medical and biological protocols to the 
microscale domain. The SELEX process, by which aptamer sequences are selected via 
isolation from randomized libraries, is a time-consuming and resource-intensive protocol 
which is being performed with increasing frequency in both academic and private sector 
laboratories. Conventional approaches using macroscale technology cannot meet the 
current demand for selection of new aptamer sequences, as they require months of work 
and liters of expensive reagents. 
Microscale approaches to the SELEX process have been receiving attention in 
recent years due to their initial successes in reducing the time and reagents necessary to 
find aptamers. In particular, microscale "selection" or partitioning of weakly bound 
sequences from aptamer candidates, and on-chip integration of the protocol have 
separately been explored as approaches to scaling and improving SELEX. Initial results 
have shown that this technology can reduce resource requirements for SELEX by at least 
an order of magnitude. 
  
In this dissertation, a new approach to on-chip SELEX is developed which 
integrates highly efficient microfluidic selection and on-chip integration of the entire 
protocol. As a result, further reductions in processing time and reagent requirements can 
be realized. A demonstration of aptamer capabilities is first achieved via the development 
of a microfluidic aptasensor for cocaine, which utilizes aptamer-coated microbeads and 
fluorescent detection. Secondly, a technology necessary for on-chip integration of 
SELEX is developed: a novel bead-based polymerase chain reaction (PCR) protocol 
which vastly simplifies procedures for the capture and resuspension of ssDNA in solution. 
This protocol is then integrated on-chip with bead-based partitioning of weakly bound 
sequences to develop a microchip which performs temperature-specific isolation of 
aptamer sequences from a randomized library. Finally, this approach is further developed 
into a microfluidic SELEX chip which is capable of performing multiple rounds of 
temperature-specific SELEX. The novel bead-based protocol is shown to efficiently 
isolate target-binding sequences from a random library in a fraction of the time 
previously reported. As a result, this research provides a schematic for the development 
of highly efficient, integrated microfluidic SELEX devices. Such devices have the 
potential to impact a variety of fields including medical diagnostics, drug detection, and 
aptamer-based therapeutics.
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Chapter 1 




 nucleic acids 
with randomized sequences (a) is introduced to target molecules (b). During selection, 
unwanted non-binding and weakly bound nucleic acids are separated from strongly 
bound aptamer candidates (c) which are then chemically amplified (d). Single-stranded 
nucleic acids are then separated from the amplified double strands prior to repetition of 
the process (e). 
Figure 1-2. The first attempt at microfluidic SELEX: the Hybarger prototype. This 
device used off-chip fluidics and temperature control, but showed that an integrated 
SELEX protocol was possible and could potentially revolutionize the field [1]. 
Figure 1-3. The CMACS (continuous flow magnetic actuated cell separation) system, 
used to separate weakly bound nucleic acids from aptamer candidates bound to target-
conjugated magnetic beads in a microfluidic selection device [2]. 
Figure 1-4. Previously reported on-chip SELEX protocol. (i) DNA library is exposed 
to target-conjugated microbeads. (ii) Incubation of the library and beads results in 
aptamer candidates binding to beads. (iii) Weakly bound strands are washed away while 
strongly bound candidates remain adhered to magnetic beads held in place using a 
magnetic field. (iv) Aptamer candidates are amplified in situ in the microchamber, 
following introduction of amplification mixture. (v) Single-stranded aptamer candidates 
are eluted and used to restart the process. It is unclear how this last step of the process 
can be completed independent of manual user intervention (pipetting). 
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Chapter 2 
Figure 2-1. (a) Schematic of the microfluidic cocaine sensor, and (b) fabrication 
process: (i) microfluidic features are defined in PDMS, (ii) heaters and temperature 
sensors are fabricated on a glass slide, (iii) the PDMS and glass slide are bonded together. 
Figure 2-2. Signal-on aptamer-based cocaine detection. (a) A fluorophore-labeled 
aptamer is immobilized onto a solid surface. (b) A quencher-labeled short complimentary 
strand is introduced, decreasing fluorescence. (c) Unlabeled cocaine binds competitively 
to the aptamer, displacing the quencher and reducing fluorescence. 
Figure 2-3. Measured electrical resistance of the temperature sensor as a function of 
temperature. 
Figure 2-4. Effect of photobleaching on the relative fluorescence over time. 
Figure 2-5. Transient response of the sensor to introduction of quencher solution. 
Figure 2-6. Transient response of the sensor to introduction of cocaine (1 μM). 
Figure 2-7. Response of the sensor to cocaine at varying concentrations. 
Figure 2-8. Time-resolved relative fluorescence as cocaine is concentrated from a 
continuous flow (2 μL/min) of a highly dilute solution (10 pM). 
Figure 2-9. Effect of temperature on relative fluorescence from a sensor incubated 
with 100 μM cocaine solution. Return of relative fluorescence to 1 indicates successful 
regeneration of the aptamer surface. 
Figure 2-10. Reuse of the sensor after regeneration. In each cycle, the sensor was first 
thermally regenerated at 37°C (A), quenched (AQ), and finally exposed to cocaine 
(AQC). 
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Chapter 3 
Figure 3-1. Device design. (a) The chip consists primarily of a PDMS chamber 
bonded to a glass slide which has been patterned with a micro heater and temperature 
sensor. Key dimensions of the PDMS microchamber have been included in projected top 
and side views (all dimensions in mm). (b) Also shown is the design of an integrated 
microfluidic device, in which weirs retain microbeads in the chamber while beads are 
exposed to streams of buffer or reagents. 
Figure 3-2. Integration of microchip bead-based PCR. Primer-coated beads permit 
separation of DNA from impurities (a,b), and amplification produces a fluorescent signal 
on the bead surfaces (c) via microchip PCR. The beads then act as a mechanism for either 
storage or collection and analysis of ssDNA following thermally-induced dehybridization 
and release (d). 
Figure 3-3. Temperature history of a typical PCR cycle. 
Figure 3-4. Effect of temperature on fluorescence measurements, n = 3. The negligible 
change in fluorescence intensity indicates that temperature cycling does not degrade dual 
biotin functionalization and hence does not affect concentration of DNA at bead surfaces. 
Error bars indicate one standard deviation from the mean. 
Figure 3-5. Gel electrophoresis analysis of PCR tests using the 181 bp B. pertussis 
DNA amplification chemistry. Gel (a) displays the results of a solution-based test, and 
gel (b) shows the results of a bead-based test. In both gels, lane (i) is a sample of PCR 
products mixed with loading buffer, and lane (ii) is a 100 bp ladder (dsDNA for length 
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reference). Arrow indicates direction of DNA movement, with smaller strands migrating 
faster. 
Figure 3-6. Effect of annealing temperature on fluorescent intensity after bead-based 
PCR, n=3, with error bars representing one standard deviation from the mean. 
Figure 3-7. Gel electropherogram showing effects of annealing temperature on 
amplified DNA following solution-based PCR. 
Figure 3-8. Effect of bead concentration on fluorescent bead intensity following PCR, 
n = 3, with error bars representing one standard deviation from the mean. Results indicate 
there is a concentration of microbeads in the reaction mixture which optimizes signal 
intensity following the PCR reaction. The students’ t-test confirms that the 200 beads/μL 
result is differentiable from the other results, p < 0.11%. 
Figure 3-9.  Investigation of DNA detection limit. Fluorescent intensity of beads 
following the PCR reactions is plotted against concentration of templates in the reaction 
mixture. Error bars indicate one standard deviation from the mean of three experiments 
(n=3), and the reaction with zero templates (control) and a 1 pM template concentration 
(the detection limit) is differentiable with a probability of greater than 95%, according to 
the students’ t-test. 
Figure 3-10.  Relationship between signal intensity and the number of PCR cycles used 
during amplification of a 1 pM sample. Mean values from multiple tests (n = 3) are 
shown, error bars indicate standard deviation.  
Figure 3-11.  Micrographs of the microchamber illustrate the process of integrated 
microfluidic bead-based PCR. In (a), a brightfield micrograph shows a microchamber in 
which beads have been inserted into the chamber and a DNA solution is being introduced 
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(fluid flowing from top to bottom). In (b), the DNA solution has been introduced, and 
template DNA is being captured from the solution onto bead surfaces by bead-bound 
reverse primers. Following PCR cycling, and washing with buffer, the fluorescent 
intensity of the microbeads was measured with minimal background fluorescence (c). 
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 nucleic acids with randomized sequences (a) is introduced to target molecules 
(b). During selection, unwanted non-binding and weakly bound nucleic acids are 
separated from strongly bound aptamer candidates (c) which are then chemically 
amplified (d). Single-stranded nucleic acids are then separated from the amplified double 
strands prior to repetition of the process (e). 
Figure 4-2. Plan view of the integrated microchip, primarily consisting of microfluidic 
selection and amplification chambers with integrated resistive heaters and temperature 
sensors. 
Figure 4-3. Characterization of the microchip. In (a), the linear relationship between 
temperature and resistor resistance for the (i) selection chamber and (ii) PCR chamber 









, respectively. The passive mixer (b) fully mixes a 
stream of buffer and dye at 5 μL/min. 
Figure 4-4. Gel electrophoresis of buffer samples containing weakly bound DNA 
washed away from target molecules during selection. The decreasing fluorescent 
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intensity with continuing washes indicates that the selection process is removing weakly 
bound DNA, leaving strongly bound DNA to eventually be captured and amplified. 
Figure 4-5. Results from fluorescent analysis of bead-based PCR amplification of 
aptamer candidates. 
Figure 4-6. Secondary structures of clones 12, 17, and 15. 
Figure 4-7. Analysis of DNA-IgE binding. IgE-coated microbeads were exposed to 
fluorescently labeled DNA, and the fluorescence intensity of the beads, indicative of the 
surface concentration of DNA, was measured. 
Figure 4-8. Temperature-dependence of DNA-IgE binding. 
 
Appendix 1 
Figure A1-1. DNA/Fluorescent Signal Generation. Primer-coated beads (a) hybridize to 
the DNA (b); an initial temperature cycle generates complementary ssDNA attached to 
the beads (c); during the following temperature cycle, fluorescently labeled primers are 
captured by the complementary ssDNA (d) and amplification generates fluorescently 
labeled dsDNA which remains attached to the beads (e). 
Figure A1-2. Calibration data for an integrated resistive temperature sensor.  
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Chapter 1: Introduction 
 
1-1 Biomedical Microelectromechanical Systems 
 The development of semiconducting materials and transistors in the latter half of 
the 20th century enabled the computing revolution, by miniaturizing the components 
necessary to perform mathematical functions. In the past 25 years, this technology has 
been adapted to miniaturize a wide variety of biomedical protocols and devices [3-7]. 
Also known as μTAS (Micro Total Analytical Systems) or Lab-on-a-Chip, these 
biomedical microelectromechanical systems (BioMEMS) devices are capable of 
performing common laboratory and clinical techniques more rapidly, cheaply, and 
efficiently than conventional technology. This is largely due to the much greater surface 
area to volume ratios typical of microfluidic devices, which can result in much higher 
efficiencies for surface-based chemical reactions. This inherent efficiency translates into 
reduced reagent consumption and minimized assay time for microfluidic protocols. In 
addition to their inherent efficiency, microdevices offer the opportunity to integrate and 
automate complex protocols, eliminating tedious pipetting steps which require large 
amounts of time and are significant sources of error. Applications of BioMEMS 
technology include biological separations, detection of analytes, and many other 
molecular biology protocols and medical applications [8, 9]. 
 
1-1.1 Affinity Binding in Microfluidics 
 A major challenge in microfluidics has been the ability to process “real” samples 
– that is, samples which have not been pretreated in some way to purify or extract the 
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intended analyte. Some of those most common technologies encountered in microfluidic 
devices are those that achieve separation of analytes from mixtures [10], to concentrate or 
purify a desired analyte prior to further analysis. Non-specific methods of separation, 
such as ion exchange and steric exclusion, are common but hindered by their inability to 
exclude impurities with properties similar to the desired molecules [10-13]. Affinity 
binding, however, captures target molecules with very high selectivity based on 
geometric and electrostatic target-ligand interactions [14]. Affinity interactions exploit a 
combination of weak intermolecular forces (ionic interactions, hydrogen bonds, 
hydrophobic interactions, and Van der Waals forces) to achieve a strong, specific bond 
[15]. In microfluidic devices, surfaces coated with affinity substances use these 
interactions to concentration and extract analytes from complex solutions prior to other 
functionalities, such as analysis. Common affinity binders used in these applications 
include antibodies (polyclonal and monoclonal), lectins, and enzymes. Arguably the most 
popular type of affinity binders are monoclonal antibodies, which are prized for their 
ability to individually target a wide variety of antigenic substances and their ability to be 
reproduced in large quantities relatively cheaply. Assays based on monoclonal antibodies 
are often capable of detecting minute quantities of target substances in complex mixtures. 
 
1-2 Aptamers 
Aptamers, discovered in 1990 by Andrew Ellington, Jack Szostak, Craig Tuerk, 
and Larry Gold, are relatively new, highly effective affinity binders [16, 17]. From Latin 
“aptus-“, “to fit,” aptamers are nucleic acids that join with target molecules via 
conformational binding, in which the structure of the nucleic acid changes to fit the 
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intended moiety. The ability of the aptamers to conform to fit their target molecule 
imparts high binding strength, as the molecules can conform to maximize the electrostatic 
and intermolecular interactions characteristic to affinity binding [18]. This is reflected by 
the dissociation constants (KD) of aptamers and their targets, which range from 





Aptamer structures include not only ssDNA and RNA, but synthetic nucleic acids such as 
locked nucleic acids (LNAs) [19], peptide nucleic acids (PNAs) [20, 21], and 
enantiomeric nucleic acids (referred to as spiegelmers) [22]. Different constituent 
components impart different characteristics to the binding sequence [23]. For example, 
ssDNA and RNA aptamers have no discernible difference in inherent binding strength 
[24]; but whereas ssDNA aptamers are more stable than RNA sequences, RNA sequences 
can potentially be expressed in vivo for therapeutic applications [25]. The aptamer 
selection process determines a nucleic acid sequence expressing binding affinity, which 
allows identical aptamers to be synthesized as needed with a wide variety of chemical 
modifications tailored to the intended application. This selection process, SELEX, which 
is evolutionary and repetitive in nature, allows for a wide variety of target molecules. 
 
1-2.1 Comparison to other affinity binders  
 Their in vitro development gives aptamers a number of advantages over 
conventional affinity binders such as antibodies or enzymes [26]. Antibodies are 
produced by provoking an immune response in host tissue, after which the antibodies are 
collected and repurposed. The reliance upon a host organism for production imparts 
several disadvantages to antibodies [15]. These include batch-to-batch variation in 
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antibody production, due to the incomplete control over the in vivo process, and the need 
for target molecules to provoke an immune response in the host organism [27]. In 
addition, antibodies are generally not reusable – after binding to a target molecule, 
separation of the antibody-antigen complex requires permanent denaturation of the 
antibody. By comparison, aptamer-target complexes can be easily broken and the 
aptamers reused, allowing for the development of regenerable devices for sensing and 
other applications.  Aptamer binding is completely reversible upon application of a 
variety of external stimuli, such as temperature or pH. In addition, nucleic acids can be 
safely stored and reused for several years after being synthesized, unlike antibodies or 
enzymes which are more easily denatured. Aptamer binding strength, as measured by the 
dissociation constant, is as strong or stronger than that of antibodies, however aptamer-
target binding can be carefully tailored during the in vitro selection process and can 
therefore be far more effective. Aptamers have been developed which discriminate 
between small molecules whose structures differ by only a single methyl group [26], and 
can readily differentiate between a protein and the synthetic enantiomer (mirror-image) 
version [22]. Despite their drawbacks, however, antibodies have been used in a wide 
variety of conventional and microfluidic assays, and are only slowly being replaced by 
aptamers in their role as biorecognition elements. 
 
1-2.2 Applications of Aptamers 
 Since their discovery, aptamers have been applied in fields such as biosensing 
[28], extraction and enrichment [29, 30], and therapeutics [31, 32]. Their wide 
applicability can be attributed to their well understood mechanism – affinity binding – 
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and their large range of potential targets. Aptamers have been developed that target 
proteins [26, 33], small molecules [34-36], whole cells [37, 38], and viruses [39-41]. 
Areas of applications for aptamers include detection of biological warfare agents [42], 
drug monitoring in human patients [43], and the treatment of cancer [44]. Aptamers have 
been recognized as a next-generation sensing element in the field of biosensing [45]. 
Aptamer-based therapeutics is a rapidly growing field, with many clinical trials currently 
underway for treatment of a range of illnesses and at least one aptamer-based drug 
currently available [46]. Pegaptanib, marketed by Pfizer and OSI Pharmaceuticals under 
the trade name Macugen, treats age-related macular degeneration by interfering with the 
pathological processes resulting in vision loss. Pegaptanib consists of an anti-VEGF 
(vascular endothelial growth factor) aptamer which has been pegylated to increase 
therapeutic dwell time [47]. Several more aptamer-based therapeutics are currently 
undergoing clinical trials for treatment of ailments such as cancer and heart disease [31, 
48].  
 In the field of microfluidic affinity binding, aptamers have been applied to a 
multitude of assays for microfluidic detection [28], separation [49], and purification [50] 
of analytes. One of the advantages of aptamers is their readily modifiable chemistry, 
which has been used to immobilize aptamers using a variety of methods such as covalent 
attachments and streptavidin-biotin linkages. As a result, aptamer-coated surfaces are 
readily available to provide biorecognition functionality in microfluidic devices [51], 
taking advantage of their inherently large surface area-to-volume ratios. Similarly, the 
range of geometries readily functionalized with nucleic acids has proven useful in a 
number of applications. In DNA-based optical detection, for example, functionalization 
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of nanostructured surfaces has been used to lower detection limits by enhancing the 
signal-to-noise ratio [52].  
 Their easily modifiable structure also lends versatility to microfluidic applications 
of aptamers by augmenting the already large array of possible functions. In aptamer-
based microfluidic sensing, for example, a number of approaches use changes in the 
aptamer structure itself to transduce binding of the target molecule. Upon binding to a 
target, aptamers undergo changes to their size, shape, charge, and other properties. These 
can be monitored using techniques such as cyclic voltammetry to electrochemically 
measure changes in surface-bound charge to report analyte detection [53]. Alternatively, 
the aptamer structure can be directly modified with molecules that report the target 
presence or conformational changes via optical, chemical, or other methods [45, 54-56]. 
As a result of these advantages, microfluidic devices using aptamer technology benefit 
from better signal-to-noise ratios, faster assay times, reduced reagent consumption, and 
reductions in necessary labor via integration and automation. 
 
1-3 Isolating Aptamer Sequences with SELEX 
 As discussed in the previous section, the protocol for determining the sequence of 
a target-binding aptamer is an evolutionary process called SELEX, or Selective Evolution 
of Ligands by EXponential enrichment [16, 17]. SELEX, as shown in Figure 1-1, 
primarily consists of repeated selection and amplification procedures which gradually 
transform a library of nucleic acids with randomized sequences into a pool of target-
binding oligomers with a conserved sequence motif expressing binding affinity to a target 
molecule. The randomized library (Figure 1a) is exposed to target molecules, during 
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which time aptamer candidates become bound to the target molecules (Figure 1b). These 
strongly bound aptamer candidates are then separated from non-binding and weakly 
bound strands (Figure 1c), and biochemically amplified (duplicated) using the 
polymerase chain reaction (PCR) (Figure 1d). Single-stranded aptamer candidates are 
then collected from the double-stranded amplified library (Figure 1e), and used to restart 
the protocol. A conventional SELEX protocol requires 10-15 “rounds” of selection and 
amplification in order to converge the library to a consensus sequence, or aptamer. The 
nucleic acid library itself consists of a 10-200 nucleotide (nt) randomized region, flanked 
by two 5 – 40 nt known sequences. The known sequences serve as priming regions for 
amplification via PCR, while the randomized region must be large enough to contain the 
sequences which define the secondary structures that form the basis of the conformational 
binding to the target molecules. Random regions are typically 30-60 nt long, as both 
shorter and longer sequences have been shown to reduce selection efficiency [57, 58]. 
Priming sequences are typically 10 – 20 nt long, to ensure maximum annealing efficiency 
during PCR and minimize non-specific amplification. 
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(a) Oligomer Library
(b) Selection (c) Separation
(d) Amplification(e) Collection
 




 nucleic acids 
with randomized sequences (a) is introduced to target molecules (b). During selection, 
unwanted non-binding and weakly bound nucleic acids are separated from strongly 
bound aptamer candidates (c) which are then chemically amplified (d). Single-stranded 
nucleic acids are then separated from the amplified double strands prior to repetition of 
the process (e). 
 
 A number of variations of this process have been demonstrated since its 
introduction in 1989 that are intended to produce varied outcomes of the process, such as 
controlled binding affinity to one or more molecules. For example, Toggle-SELEX [59, 
60] and Counter-SELEX [61] generate binding affinity to multiple targets and eliminate 
affinity to undesired targets, respectively [62]. Non-SELEX requires no amplification, 
only selection, to generate aptamers [63], and Photo-SELEX uses photo-reactive groups 
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in the nucleic acid structure [64, 65]. In general, however, the aforementioned protocol 
acts as the template for a SELEX procedure intended to produce a ligand that binds to a 
target molecule. 
 
1-3.1 Conventional SELEX Technology 
 The technology necessary to perform SELEX is not particular to this protocol; the 
two main aspects of SELEX, separation and amplification, are well-known biological 
protocols that have been extensively studied. SELEX almost exclusively relies upon PCR 
for amplification rather than rolling cycle amplification (RCA) or nucleic acid sequence 
based amplification (NASBA), due to the ability of PCR to rapidly generate duplicates of 
any DNA sequence based on a known priming region. A variety of different methods, 
however, are employed to separate the strongly-bound candidate aptamers from the 
random library during selection. Technology typically used for conventional selection 
includes substrates found in other implementations of affinity chromatography. 
Nitrocellulose filter paper, for example, retards the movement of positively charged 
particles (including proteins), while allowing negatively charged nucleic acids without 
bound targets to pass through [66]. Another very common technique is to couple the 
target molecule to an agarose or sepharose matrix in an affinity column [62]; such 
methods allow relatively simple control over selection stringency, by varying the 
intensity of the buffer washes used to wash away weakly bound nucleic acids. Other 
previously-reported techniques include solid-phase methods like SPR (surface plasmon 
resonance) [67], antibody-based methods [68], flow cytometry [69], and the use of 
magnetic beads [70]. Separation of non-binding strands from aptamer candidates bound 
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to targets immobilized onto magnetic beads is a highly effective separation method [71], 
and this approach has been adapted in microfluidic implementations. ”Solution-phase” 
separation procedures, such as electrophoresis, have also been applied to selection with 
the added advantage that they allow maximum binding between the target molecule and 
the library. Solution-phase methods include capillary and gel electrophoresis [72, 73], 
centrifugation [74], and electrophoretic mobility shift (EMSA) [75]. An advantage of the 
SELEX process is that it is flexible; it can be changed to meet the specific needs of the 
intended target molecule or application. As a result, there is a large variety of selection 
methods available, each with particular advantages and disadvantages [40]. 
 While conventional SELEX technology is capable of generating high affinity 
aptamers (KD of approximately 1 nM) for a wide range of targets (proteins, cells, etc.), it 
requires an immense amount of time and effort [76]. Conventional PCR reactions often 
require more than 45 minutes for thermal cycling alone, in addition to the necessary 
preparation time. Selection procedures are intensely laborious [40, 76], as they require 
many tedious pipetting steps that must be performed carefully by a trained technician. 
This time and effort is multiplied by the 15 to 20 rounds of SELEX required for a high 
affinity aptamer to be generated. The resource requirements of each step is multiplicative 
– the thousands of pipetting steps necessitate careful controls and additional procedures 
to ensure that, should an error occur, the process can be restarted without loss of data. As 
a result of these issues successful SELEX procedures require months of intense effort by 
highly trained personnel. This is the largest single drawback to more widespread use of 
aptamers. 
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 In response to the large resource requirements of SELEX and the high demand for 
aptamers, great strides have been taken in recent years to improve the techniques for 
generation of aptamers. Initial efforts focused on automating SELEX using robotics, but 
this required large amounts of startup funding to purchase the required equipment [70, 77, 
78]. More recently, microfluidic technology has been applied to this problem in an 
attempt to increase selection and protocol efficiency via automation and the high surface 
area to volume ratios inherent in BioMEMS devices. 
 
1-3.2 Microfluidic SELEX Implementations 
 Microfluidics provides a clear answer to the issues associated with performing the 
SELEX protocol. The advantages that microfluidics imparts to biological protocols – 
greater efficiency, shorter assay times, and automated reactions – are of direct importance 
to SELEX. In the past decade, efforts have been made to miniaturize SELEX protocols 
onto microfluidic chips, attempting to realize the benefits that could be conveyed to the 
field of aptamer applications by miniaturizing the aptamer generation process [76]. These 
efforts have met with only mixed success.  The first reported “microfluidic SELEX” 
device consisted of silica microlines connected to a complex system of dye-actuated 
valves (Figure 1-2) [1]. This device proved that the operations required for SELEX could 
be performed in an integrated device without the pipetting steps that make the 
conventional protocol so tedious, but failed to enrich a randomized library and was not 
truly “microfluidic” in that it used off-chip valves and capillaries and off-chip heaters for 
control of fluid flow and temperatures, respectively. 
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Figure 1-2. The first attempt at integrated microfluidic SELEX: the Hybarger prototype. 
This device used off-chip fluidics and temperature control, but showed that an integrated 
SELEX protocol was possible and could potentially revolutionize the field [1]. 
 
Following the publication of this work, efforts primarily focused on developing a more 
efficient microfluidic selection protocol. While microfluidic amplification had been 
explored extensively [79-81], microfluidic partitioning of non-binders from candidate 
aptamers was a novel approach and it was thought that the intrinsic efficiency of surface-
based reactions in microfluidic devices would benefit solid-phase selection procedures. 
Similar to affinity chromatography using columns, target molecules were immobilized 
onto microbeads and exposed to randomized libraries [82]. Separation was achieved 
using a combination of hydrodynamic flow to remove the weakly bound nucleic acids 
and a magnetic field to physically isolate the magnetic beads (Figure 1-3). The initial 
attempt succeeded in generating an aptamer against Botulinum Neurotoxin with a KD of 
approximately 33 nM after only a single round of selection, and subsequent efforts have 
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shown that the same technology can be used to achieve very high efficiency partitioning 
for separation of high-affinity ligands during SELEX [2, 82-85]. 
 
 
Figure 1-3. The CMACS (continuous flow magnetic actuated cell separation) system, 
used to separate weakly bound nucleic acids from aptamer candidates bound to target-
conjugated magnetic beads in a microfluidic selection device [2]. 
 
The efficiency of microfluidic selection stems from the higher surface area-to-volume 
ratios of such devices and the nature of competitive binding during selection. As 
experimental and numerical studies have confirmed, the key to generating a stringent 
selection protocol is maintaining a high ratio of free nucleic acids to available target 
molecules [86]. Consider the definition of the dissociation constant expressed as  








  Eq. 1.1 
where [NAf] represents the concentration of free nucleic acids, [Tf] that of the free target 
molecules, and [{T:NA}] is the concentration of bound target-nucleic acid complexes. 
While the total number of nucleic acids must remain high to ensure the possibility of 
finding the strongest binder, and the ratio [NAf]/[{T:NA}] is a constant for each round of 
SELEX, [Tf] may be kept very small during selection to exert downward pressure on KD 
(the desired outcome). While this can be accomplished by using a very large volume for 
selection, this approach is unwieldy, time-consuming, and produces low dissociation rate 
constants that may be undesired [85]. Alternatively, target molecules immobilized onto a 
surface in a high surface area-to-volume ratio reaction chamber can maintain this ratio 
while minimizing the size of the reaction volume. The associated reduction in average 
path length (the distance a nucleic acid must travel to associate with a target molecule) 
means that the competition process requires less time, thereby reducing the time 
necessary for selection.  
 
Finally, most recently there have been efforts made towards developing a fully-integrated 
microfluidic SELEX chip that performs both selection and amplification on-chip. The 
integration of those protocols would create the most efficient SELEX procedure, by 
minimizing the time and reagents necessary to perform both selection and amplification, 
and simultaneously performing a more effective selection with far less potential for 
human error. Some of the recent attempts achieving this goal show great promise, while 
still falling short of generating a fully capable SELEX device. The most relevant devices 
have used a similar magnetic-bead-based approach to microfluidic selection, and have 
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performed selection and amplification in a single microfluidic chamber [87, 88]. These 
devices have been shown to be capable of developing aptamers targeting proteins with 
nanomolar sensitivities, and achieve “sample-in aptamer-out” results similar to those 
achieved in integrated microfluidic detection devices [89-91]. However, the execution of 
the protocol itself leaves significant room for improvement, particularly with respect to 
selection and integration of amplification. In particular, the devices are incapable of 
selecting aptamers in buffer conditions besides those used for PCR, due to the single-
chamber design (Figure 1-4). It is also unclear how collection of single-stranded library 
DNA is possible following amplification, and the resultant contamination of the aptamer 
pool with complementary DNA prior to further selection results in competition between 
these complementary strands and the target molecules for the aptamer candidates. This 
competition results in decreasing selection efficiency with each SELEX round, which 
may contribute to the apparent decrease in selection efficiency as compared to that 
reported in microfluidic selection devices using similar separation technology (6 rounds 
of SELEX as compared to 1 – 3). 
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Figure 1-4. Previously reported on-chip SELEX protocol [87]. (i) DNA library is 
exposed to target-conjugated microbeads. (ii) Incubation of the library and beads results 
in aptamer candidates binding to beads. (iii) Weakly bound strands are washed away 
while strongly bound candidates remain adhered to magnetic beads held in place using a 
magnetic field. (iv) Aptamer candidates are amplified in situ in the microchamber, 
following introduction of amplification mixture. (v) Single-stranded aptamer candidates 
are eluted and used to restart the process. It is unclear how this last step of the process 
can be completed independent of manual user intervention (pipetting).  
 
  17 
  
In summary, the present work in microfluidic aptamer generation demonstrates that 
microfluidics is capable of providing a highly efficient aptamer generation platform, but 
has yet to achieve its full potential. The capabilities of the most popular microscale 
SELEX protocols are compared to a conventional method in Table 1-1. Microfluidic 
selection has been proven highly effective as a standalone module, and integrated SELEX 
devices have demonstrated improvements in time and resource efficiency, but integrated 
SELEX devices have yet to achieve highly effective selection. Achieving this goal is the 
focus of this dissertation. 
 
Table 1-1. Comparison of a conventional SELEX protocol (affinity column separation 
and conventional PCR) to newer microscale methods. 








Affinity Column 10 - 20 Days Months No 
Robotic [70] 15 - 20 4 hours 3 days Yes 
Sol-gel [92, 93] 7 - 9 3.5 hours 3 days No 
Capillary Electrophoresis [94] 1 - 3   2 days No 
Microbead μFluidic SELEX [88] 6 2 hours 1 day Yes 
M-SELEX [2, 82] 1 - 3 2 hours 1 day No 
 
 
1-4 Significance of This Work 
 Aptamers hold the promise of revolutionizing fields such as biosensing and 
therapeutics, but this potential has been hampered by the lack of available aptamers for 
potential targets. The detection of bioterror agents, identification of trace compounds, and 
cancer research are all fields of active aptamer-related research that are tremendously 
slowed by the requirements of SELEX. This problem - the immense effort necessary to 
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generate aptamers – is the problem which this dissertation addresses. Aptamer generation 
primarily consists of two procedures: a separation of nucleic acids, and biochemical 
amplification. These procedures, separately, have been the subject of a great deal of 
microfluidic research, but have not been effectively executed and combined to create an 
efficient microfluidic SELEX device. By integrating them to perform SELEX, dramatic 
advances in a number of fields would be enabled vis-à-vis the much greater availability 
of aptamers for potential targets. In particular, this dissertation addresses two key issues 
with the current state of the art in microfluidic SELEX devices: integration of highly 
efficient microfluidic selection and amplification to maximize efficiency, and 
temperature-specific microfluidic selection. 
 
1-4.1 Integration of microfluidic selection and amplification for highly efficient 
SELEX 
 A key failing of previous microfluidic SELEX implementations has been that the 
most efficient selection protocols, those found in microfluidic devices, have not been 
integrated to perform microfluidic SELEX on-chip. These protocols, in which 
hydrodynamic flows separate unwanted nucleic acids from those bound to target-
conjugated magnetic beads held in place with a magnetic field, are capable of developing 
high-affinity aptamers in 1 to 3 rounds of selection. However, users still perform 
conventional PCR and manually pipette solutions during the process, requiring more time 
and increasing the opportunity for user-introduced errors. In addition, the integrated 
devices developed thus far do not effectively couple the amplification and selection 
protocols, resulting in loss of efficiency due to contamination of the candidate pool with 
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unwanted nucleic acids. This dissertation will exploit a bead-based PCR scheme to 
successfully integrate highly effective microfluidic selection with microscale PCR in an 
integrated device to generate high-affinity aptamers in the shortest time possible. 
 
1-4.2 Temperature-specific microfluidic selection 
 The ability to predetermine binding traits has been an active area of investigation 
in SELEX research. For example, approaches have been developed to allow selection of 
aptamers with particular dissociation constants (KD) and thermodynamic binding 
characteristics [95, 96]. In addition, the temperature-sensitive nature of aptamer-target 
binding has been exploited to develop aptamers which bind to targets at predetermined 
temperatures [33, 69]. With conventional selection technology, this is particularly time-
consuming, as the experimental setup is cumbersome. In this dissertation, local 
temperature control on microfluidic chips is exploited to enable highly accurate 
temperature-specific selection of target-binding aptamers. The significance of this 
improvement is twofold: firstly, all previous microfluidic SELEX devices implement 
isothermal selection. Incorporation of temperature specificity in the microfluidic selection 
protocol is therefore highly novel. Second, temperature control during selection is not a 
thoroughly explored aspect of aptamer selection, most likely due to the difficulties 
associated with implementing temperature-specific selection with conventional SELEX 
equipment. The use of temperature as a second domain across which to isolate target-
binding sequences may have important implications in the larger field of SELEX. 
Therapeutics is rapidly becoming a very popular area of aptamer research, and aptamers 
intended for in vivo applications benefit from increased binding strength at physiological 
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temperatures. While temperature-specific binding has previously been demonstrated, it 
may be possible to select aptamers with a wider range of temperature stability. This trait 




This work represents the first time a microfluidic SELEX device with integrated 
temperature-specific selection has been reported. In addition to performing SELEX, the 
devices exploit another newly developed technology, microfluidic bead-based 
polymerase chain reaction, to allow successful on-chip integration of highly efficient 
selection with amplification. The dissertation also describes a novel microfluidic cocaine 
aptasensor, which uses the same bead-based microfluidic platform to perform highly 
specific detection of cocaine. 
  
1-5 Organization of dissertation 
 This dissertation develops the technology necessary to fabricate and operate an 
integrated microfluidic SELEX device which generates high-affinity aptamers with 
temperature-specific binding properties. Following this introduction, Chapter 2 discusses 
the implementation of a microfluidic aptasensor for cocaine which uses microbeads as an 
affinity binding surface. This device develops the bead-based microfluidic architecture 
that will be applied in following chapters. Chapter 3 builds upon the bead-based 
microfluidic platform by demonstrating a microfluidic bead-based polymerase chain 
reaction device that is capable of integrated operations. This device is shown to be 
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capable of detecting DNA, but also functions as a DNA capture and purification 
component of an integrated microfluidic device. In Chapter 4, the bead-based PCR device 
is integrated with a microfluidic selection chamber, demonstrating that this strategy for 
an integrated SELEX device is feasible by performing a single round of SELEX. In 
Chapter 5 this design is further developed by “closing the loop,” performing multiple 
rounds of SELEX in an integrated microfluidic device. Future work and conclusions will 
be presented in Chapter 6. 
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The detection and quantification of trace amounts of illicit substances such as 
cocaine continues to be important for law enforcement and clinical medicine. Law 
enforcement officials must be able to detect trace amounts of cocaine in probationary 
offenders, and larger concentrations concealed by suspected users employing masking 
agents. In clinical medicine the detection of street drugs in patients of pain management 
practices requires frequent testing [97] that can be prohibitively expensive. Conventional 
methods available for cocaine detection include chromatography, presumptive testing, 
and immunoassays. Among these, gas chromatography-mass spectrometry (GC-MS) 
continues to be the gold standard in illicit material detection [98] given its sensitivity and 
reliability. Other chromatographic techniques, such as liquid chromatography (LC) and 
thin-layer chromatography (TLC) are also commonly used. In GC a sample of analyte is 
pushed through a column of adsorbent media, separating the constituents. LC systems are 
very similar, using a liquid as the carrier fluid instead of a gas, and TLC draws fluids 
across an adsorbent using capillary action. Unfortunately, GC-MS is inherently expensive, 
requiring a great deal of time, complicated equipment, and trained personnel. LC is 
typically even more expensive, and along with TLC gives poorer results due to its limited 
separation efficiency [99]. A more time-efficient alternative to chromatographic methods 
is presumptive testing using colorimetric reagents that rapidly react with a number of 
chemicals, but this approach is limited by a lack of specificity in that the reagents react 
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non-specifically with target analytes [100, 101]. To address the limitations of 
conventional techniques for detecting cocaine such as non-specificity and expense, the 
use of affinity sensing is highly attractive. 
In affinity sensing, a target analyte is recognized by affinity binding with a 
receptor. That is, the analyte and receptor molecules join via specific hydrogen bonds, 
stacking of moieties, and analyte-induced receptor conformational changes which result 
in highly specific and reversible binding. Commonly used affinity receptors include 
antibodies, lectins, enzymes, and in particular, aptamers [102]. Aptamers are single 
stranded DNA and RNA oligonucleotides specifically selected for their binding affinity 
towards a specific target molecule [103]. Exposure to a target molecule induces 
conformational changes in aptamer structure facilitating binding that is both highly 
specific and reversible. Aptamers are easily chemically modified and are generated in 
vitro, resulting in no batch-to-batch variation in binding efficiency. As such, aptamers are 
attractive affinity receptors for cocaine detection. For instance, colorimetric sensing of 
cocaine was reported using aptamers conjugated to gold nanoparticles [104, 105]. 
Additionally, UV absorption spectroscopy combined with aptamer-based solid-phase 
extraction was used to detect cocaine at micromolar concentrations in complex media on 
a large-scale liquid chromatography platform [106]. Cocaine sensing using aptamers has 
also been demonstrated using Raman scattering methods, in which aptamers bound to a 
silver colloid surface and labeled with a Raman reporter allowed detection of micromolar 
quantities of cocaine [107]. Furthermore, cocaine binding with a surface-immobilized 
aptamer can be measured via reduction of an electroactive species tethered to the distal 
end of the aptamer. This has allowed cocaine detection at the micromolar level using 
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electrochemical methods [108], or with 1 nM detection limits using 
electrochemiluminescent methods [109]. Implemented on conventional platforms, these 
aptamer-based cocaine sensing approaches generally involve large reagent consumption, 
require bulky equipment, and are labor-intensive. These limitations hinder the realization 
of cocaine detection in portable, user-friendly systems.  
Miniaturization technology holds potential for rapid, sensitive detection of 
cocaine with minute sample quantities. A microfluidic adaptation of a standard 
presumptive test for cocaine was fabricated, consisting of a microchannel into which was 
deposited a small amount of cobalt thiocyanate [110]. While still limited by conventional 
presumptive testing, the microfluidic device led to reduced sample consumption and 
allowed for device regeneration. In a different approach, a microfluidic sensor based on 
antibodies attached to a quartz crystal microbalance demonstrated rapid detection (<1 
minute) of nanograms of cocaine [111]. However, the use of antibodies makes the sensor 
regeneration difficult, and may also lead to batch-to-batch variations in sensor 
performance. More recently, a microfluidic continuous-flow aptasensor was reported that 
uses an electrochemical method for detection of cocaine amongst other compounds in 
blood serum-based samples [43]. Micromolar detection limits were demonstrated. 
 This chapter presents a microfluidic aptamer-based biosensor for cocaine that uses 
a cocaine-specific DNA aptamer modified with a fluorophore. Based on a device 
architecture designed for highly specific solid-phase extraction [112, 113], this sensor is 
capable of low-cost quantitative cocaine detection in a highly specific, signal-on, and 
label-free manner. The device is demonstrated to be capable of specifically detecting 
cocaine at concentrations as low as 10 pM, with a linear response over four orders of 
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magnitude. Additionally, the device can be conveniently regenerated for reuse by a 
modest temperature change via on-chip temperature control. As such, the device can 
potentially be used for sensitive and rapid detection of cocaine in practical clinical and 
law enforcement applications. 
 
2-2 Principle and Design 
 The device consists of a microfluidic chamber and channels fabricated from 
(poly)dimethylsiloxane (PDMS) and bonded to a glass substrate integrated with a 
resistive micro heater and temperature sensor (Figure 2-1a). The inlet and outlet 
microchannels are utilized for sample and buffer introduction and removal from the 
device, while an auxiliary microchannel is used for bead packing. Microweirs (15 μm 
high) separate the microchamber (130 μm high) from the inlet and outlet microchannels 
and serve to retain the beads in the microchamber. The on-chip microheater has a 
serpentine layout and directly covers the microchamber area to facilitate uniform heating 
of the microchamber area. A resistive temperature sensor is placed at the center of the 
microchamber to provide accurate temperature measurement for thermal control. The 
device was fabricated using soft lithography and lift-off techniques (Figure 2-1b). A mold 
was fabricated from the negative photoresist SU-8, and a 10:1 mixture of PDMS pre-
polymer and curing agent was cast over the mold to fabricate microchannels in a PDMS 
slab. This was bonded to a glass slide with integrated heaters and sensors. Details of the 
fabrication process are described elsewhere [113].  




















Figure 2-1. (a) Schematic of the microfluidic cocaine sensor, and (b) fabrication process: 
(i) microfluidic features are defined in PDMS, (ii) heaters and temperature sensors are 
fabricated on a glass slide, (iii) the PDMS and glass slide are bonded together. 
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 A Förster resonance energy transfer (FRET) system is utilized to signal cocaine 
binding to the aptamer. FRET systems involve the coupling of a fluorescent molecule that 
emits visible light (fluorophore) to another fluorescent molecule that absorbs visible light 
and emits at invisible wavelengths (quencher). Carboxyfluorescein (FAM) is used in this 
work as a visible-range fluorophore, which, attached to a cocaine-specific aptamer 
(below), is characterized by a peak absorption wavelength of 494 nm and a peak emission 
wavelength of 518 nm [114]. Dabcyl is employed as a quencher molecule, which absorbs 
light over a wide range of wavelengths and dissipates the light as infrared energy. When 
placed in close proximity to FAM, Dabcyl causes a drastic reduction in visible emission 
during excitation at 494 nm. To exploit the FRET system within the microfluidic device 
for aptamer-based cocaine detection, a DNA aptamer is employed that is adapted from 
the sequences originally obtained for free solution aptamer-cocaine binding [34]. A FAM 
molecule is attached to the 5′ end of the aptamer, and a biotin molecule at its 3′ end. This 
allows the aptamer to be immobilized onto a streptavidin functionalized surface via 
biotin-streptavidin interaction with the FAM molecule at the free end (Figure 2-2a). In 
order to establish a baseline signal, a Dabcyl molecule, attached to the 3′ end of a short 
DNA strand complementary to the aptamer, is introduced. This strand hybridizes to the 
distal end of the aptamer (Figure 2-2b), bringing the FAM fluorophore and Dabcyl 
quencher into close proximity. Thus, the baseline consists of a drastically reduced level 
of fluorescence. Upon introduction of unlabeled cocaine (i.e. cocaine molecules not 
altered by any labeling group for transduction), the aptamer selectively and conformably 
binds to the cocaine, which disrupts the interaction of the relatively weaker binding 
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quencher strand, as shown in Figure 2-2c. The displacement of the Dabcyl molecule 
results in a recovery of fluorescence (i.e., a signal-on response) in proportion to the 
concentration of cocaine. In this manner, the device accomplishes signal-on, label-free 







Figure 2-2. Signal-on aptamer-based cocaine detection. (a) A fluorophore-labeled 
aptamer is immobilized onto a solid surface. (b) A quencher-labeled short complimentary 
strand is introduced, decreasing fluorescence. (c) Unlabeled cocaine binds competitively 
to the aptamer, displacing the quencher and reducing fluorescence. 
 
2-3 Experimental 
2-3.1 Materials and Instrumentation 
 DNA was obtained from Integrated DNA Technologies (IDTDNA), Coralville, 
IA, in lyophilized form. The aptamer is of sequence 5′-FAM-A TCT CGG GAC GAC 
AGG ATT TTC CTC AAT GAA GTG GGT CGT CCC-Bio-3′, and the quencher-
modified short complimentary strand is of sequence 5′-GTC GTC CCG AGA T-Dabcyl-
3′. A stock concentration of each strand at 100 μM concentration was created using buffer 
solution consisting of pH 7.4 Tris-HCl, 150 mM NaCl, 5 mM KCl and 2 mM MgCl2. 
Stock solutions were then diluted and aliquoted prior to testing. Ultralink Streptavidin-
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coated microbeads (80 – 120 μm in diameter) consisting of a copolymer of bis-
acrylamide and azlactone were obtained from Thermo Scientific Pierce Protein Research 
Products. Microfabrication materials such as SU-8 2050, 2100 (MicroChem) and  S1818 
(Microposit), Sylgard 184 PDMS (Dow Corning), glass microscope slides (Fisher 
Science), and glass capillary tubing (Polymicro Technologies) were purchased from 
Microchem, Robert McKeown, Fisher Science, and Polymicro Technologies respectively. 
Fluorescence measurements were conducted on a Nikon Diaphot 300 Inverted 
Fluorescence Microscope coupled to a CCD digital camera (Micrometrics 190CU) and a 
Nikon HB-10103AF light source. Thermal measurement and feedback were conducted 
using a LabView program incorporating a proportional-integrative-derivative (PID) 
controller, 5½ digit NI PCI-4060 PCI digital multimeter card, and Agilent E3631A Power 
Supply. A New Era Pump Systems syringe pump model NE-1000 was used for 
pneumatic flow actuation. 
 
2-3.2 Experimental Protocol 
 The temperature dependence of resistivity of the temperature sensor was 
characterized using an environmental chamber, where the internal temperature was 
monitored with a platinum resistance temperature detector (RTD) probe (Hart Scientific 
5628) and benchtop digital multimeter (Agilent 34420A). The temperature sensor 
resistance exhibited a linear response over the experimental temperature range. A 
temperature coefficient of resistance for the sensor can be calculated using equation 2.1. 
  Eq. 2.1  
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Following thermal characterization, the microbeads were introduced into the 
biosensor prior to experimentation. A buffer diluted sample of microbeads was pumped 
through the bead inlet until complete packing was achieved. This inlet was then sealed 
and the sensor placed in an enclosure on the microscope stage to block ambient light. A 
10 μL sample of 2 μM aptamer solution was then introduced into the microchamber at 2 
μL/min via the solution inlet. Following incubation and a wash with 10 μL of pure buffer, 
this step was repeated. This procedure was then repeated with 2 samples of 5 μM 
quencher solution. In every such procedure, two samples of solution (aptamers or 
quenchers) were used to ensure adequate and uniform coating of the microbeads. Images 
were taken after each wash with buffer solution to provide baseline fluorescence readings. 
When testing the response of the sensor to a concentration of cocaine, similar procedures 
were used for sample introduction with the exception that one sample of cocaine was 
used, followed by a wash in pure buffer. When testing the ability of the sensor to 
concentrate cocaine, the subsequent buffer wash was omitted. 
After each introduction, incubation and washing procedure involving aptamers, 
quenchers, or cocaine, the sensor was briefly (<5 s) excited with blue light using the 
fluorescent light source. Image acquisition was accomplished by opening the microscope 
shutter to the fluorescent light source and exciting a darkfield image of the transparent 
sensor. Resulting fluorescent emissions were captured by the inverted microscope and 
recorded by the attached Micrometrics CCD camera and associated software. Digital 
photographs were then analyzed using ImageJ software, brightness intensity was 
measured, and these values were used to calculate values of relative fluorescence. The 
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sensor was otherwise kept in a dark environment to minimize the effect of 
photobleaching. 
 
2-4 Results and Discussion 
2-4.1 Device Calibration 
Prior to testing with cocaine detection, the response of the on-chip temperature 
sensor and the effect of photobleaching on the system were characterized. Measurements 
show that the resistance of a typical temperature sensor varies linearly with temperature 
in the desired experimental range (Figure 2-3) with a temperature coefficient of resistance 




. The effect of photobleaching on the biosensor was then 
tested with an aptamer-functionalized bead packed microchamber (Figure 2-4). Over a 
time period representative of this work, the signal changes by approximately 4%, a 
negligible rate of decay. These results indicate that photobleaching can be eliminated as a 
potential source of signal drift during the cocaine sensing experiments.  
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2-4.2 Transient Response 
 For accurate fluorescence measurements, the aptamer-binding system must have 
reached equilibrium prior to exciting the fluorophores and acquiring a signal. To ensure 
this was achieved during experimentation, the transient response of the biosensor 
following introduction of all sample types (aptamers, quenchers, and cocaine) was 
characterized. The transient fluorescent response to addition of aptamers was found to be 
near instantaneous (data not shown). To test the transient response of the quenchers, a 
standard 5 μM sample of quencher solution was introduced and fluorescence response 
was measured intermittently over a period of 8 minutes (Figure 2-5). The transient 
response of the biosensor to quencher introduction was slower than that of aptamer 
introduction, with full quenching occurring within 8 minutes. This time response is most 
likely a result of the difference in kinetics between biotin-streptavidin binding and the 
hybridization of the complimentary strand to the aptamer. As a result, all future 
quenching solutions were allowed to incubate for at least 10 minutes before cocaine 
introduction. 
 





























Figure 2-5. Transient response of the sensor to introduction of quencher solution. 
 
Subsequently, the time-dependent fluorescence response of the sensor to 
introduction of cocaine was measured. Specifically, a 1 μM sample of cocaine was 
introduced to a prepared sensor and the fluorescence response was measured versus time 
for six minutes (Figure 2-6). Fluorescence intensity appeared to achieve steady state after 
a period of approximately three minutes, indicating that the sensor has a time constant of 
approximately 1.2 minutes, and a settling time of almost 5 minutes with respect to 
cocaine. This result was expected, as the aptamers express a higher affinity for the 
cocaine molecules than the quencher-labeled short complimentary strands but lower than 
that of a biotin-streptavidin interaction. As a result, equilibrium with the target analyte 
was achieved at a faster rate than with the quencher molecules, but slower than with 
introduction of aptamers alone. This test was repeated at several other cocaine 
concentrations with similar results (data not shown), indicating that the transient response 
was independent of the concentration of cocaine being tested. During subsequent 
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experiments, a cocaine sample would be incubated before washing for at least five 
minutes to ensure complete interaction of the cocaine and aptamer for maximum 
fluorescence response. This information was also used to estimate a flowrate necessary 




























Figure 2-6. Transient response of the sensor to introduction of cocaine (1 μM). 
 
2-4.3 Detection of Cocaine 
The response of the sensor to various concentrations of cocaine was then tested. 
The sensor was tested using practically relevant concentrations of cocaine, from 1 nM to 
100 μM, in a buffer solution designed to mimic the environmental conditions (pH, salt 
content) of human bodily fluid (Figure 2-7). Previously published data indicated that for a 
single dosage of cocaine, the maximum concentration of cocaine in the blood plasma of 
the user would be 1 μM [115]. As concentrations higher than 1 μM may be of interest in 
law enforcement forensics, a test at a concentration of 100 μM was included as well. The 
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sensor exhibits a considerably linear response over the range of concentrations tested, 
indicating a four orders of magnitude linear range. As an experimental control, 
introduction of a control molecule, Deoxycholic Acid (DCA) in the identical 
concentration range, was also performed using the biosensor. DCA was chosen given its 
structural similarity to cocaine and common presence in the body. No appreciable signal 
was observed above a relative fluorescence of 0.2 for even the largest tested 
concentration (1 mM), which is equivalent to that of approximately 10 nM cocaine. 
Although this would indicate detection ambiguity during experiments involving low 
concentrations of cocaine, this is not anticipated to occur in practice since physiological 
DCA concentration is relatively low compared to tested levels [116]. It is concluded from 
this data that the sensor is capable of detecting practically relevant concentrations of 
cocaine and compares well with previously reported aptamer-based cocaine sensors [105, 
108]. A relatively large degree of variability from test to test can be observed from Figure 
2-7, where error bars are computed based on three independent tests. Analysis suggests 
that this can be largely attributed to the limited resolution of the rudimentary fluorescence 
microscopy system used for this study. Therefore, it is anticipated that improved 
fluorescence imaging would considerably reduce this variability. Additional sources of 
error may include variations in bead packing density, the presence of bubbles in the 
sensing chamber, and loss of sample due to dead volumes. These issues will be 
investigated in future work. 
 












































Figure 2-7. Response of the sensor to cocaine at varying concentrations. 
 
2-4.4 Improving Detection Limits by Continuous-Flow Concentration 
 Previous work has demonstrated the ability of aptamers to concentrate and purify 
target analytes [113]. Due to the equilibrium-binding nature of the aptamer-analyte 
system, repeated exposure of the sensing surface to low concentrations of target analyte 
results in continued extraction of the analyte from the solution. Here, this phenomenon is 
exploited to concentrate dilute samples of cocaine for subsequently improved detection. 
The sensor was continuously infused with a sample of 10 pM cocaine solution at a rate of 
2 μL/min. This flowrate was calculated based on the size of the sensing chamber (1 μL) 
and the transient response of the sensor to introduction of cocaine. As a result of the 
increasing concentration of cocaine at the sensing surface, the relative fluorescent signal 
increased to a value similar to a much higher concentration of cocaine (Figure 2-8). At 
time intervals of 5 to 30 minutes, fluorescence intensity was measured, which increased 
until a saturation value of approximately 0.18 relative units was achieved after 175 
minutes. This fluorescence value corresponds to a single sample of 5 nM cocaine, 
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indicating that the sensor concentrated the cocaine by a factor of 500. This technique 
allows for detection of trace amounts of cocaine in concentrations otherwise undetectable 
































Figure 2-8. Time-resolved relative fluorescence as cocaine is concentrated from a 
continuous flow (2 μL/min) of a highly dilute solution (10 pM). 
 
2-4.5 Thermally Based Device Regeneration 
 There are many device applications for which continued reuse of a single sensor 
would be advantageous. This device makes use of the temperature-sensitive nature of 
aptamer-analyte binding to render it fully reusable. In order to investigate the ability of 
the sensor to be regenerated, the effect of temperature on the sensing surface was tested 
(Figure 2-9). Following introduction of a 100 μM sample of cocaine, the on-chip heater 
and temperature sensor were used to raise the temperature of the chamber from room 
temperature to 37°C while flowing pure buffer solution at 10 μL/min. Upon starting the 
test, a small increase in relative fluorescence at low temperatures was witnessed. This is 
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likely attributed to hydrodynamic forces removing a small amount of quencher strands 
prior to the onset of temperature-induced conformational changes. As the chamber 
temperature was increased, a larger change in fluorescence intensity was seen at 
approximately 33°C. This indicates that at this temperature, changes in the secondary 
structure of the aptamer result in the release of the cocaine molecule and leftover 
quencher strands. Signal increase continued until it saturated at approximately 37°C at a 
value of 1, demonstrating successful regeneration of the aptamer surface. This indicates 
that the sensor can be heated to a relatively modest temperature to effectively release 
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Figure 2-9. Effect of temperature on relative fluorescence from a sensor incubated with 
100 μM cocaine solution. Return of relative fluorescence to 1 indicates successful 
regeneration of the aptamer surface. 
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 In order to be fully regenerable, the device must retain functionality following 
thermal release of cocaine. The device was subjected to multiple sensing cycles using a 
changing concentration of cocaine for each cycle (Figure 2-10). In each cycle, the 
standard procedure for testing a concentration of cocaine was used, followed by thermal 
regeneration that was implemented by raising the temperature of the sensing chamber to 
37°C while flowing pure buffer through the chamber at 10 μL/minute.  The hatched bars 
indicate relative fluorescence following regeneration (surfaces coated with aptamers 
only). Gray bars indicate quenched sensors, and the black bars indicate sensor response to 
incubation of a sample of cocaine. The data indicates that the device behaves predictably 
without significant drift, with the response to cocaine concentration changing predictably 
with each consecutive test. The device was capable of detection of 1 nM cocaine 
concentration after regeneration (data not shown). Thus, modest heating and washing 
grants the device repeated use without loss of functionality, an improvement over 
previously reported cocaine sensors [108, 111]. 
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Figure 2-10. Reuse of the sensor after regeneration. In each cycle, the sensor was first 




Detection of trace amounts of illicit substances such as cocaine continues to be an 
important function in law enforcement and clinical medicine. Prevalent methods of 
detection in these fields such as GC-MS and presumptive testing allow for either accurate, 
specific detection involving expensive testing or rapid, economized detection that is 
unreliable due to its lack of specificity. This chapter describes a novel microfluidic 
fluorescence aptamer-based biosensor which can rapidly detect low concentrations of 
cocaine. The device is characterized by high selectivity and sensitivity (10 pM), as well 
as rapid response and reduced sample consumption. The transient response of the sensor 
(equilibration in less than 5 minutes) is comparable to the detection time of cocaine in a 
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GC-based system, but with the potential to bypass the need for cumbersome equipment 
and highly-trained technicians. When testing samples of cocaine, the sensor responded 
linearly to cocaine concentration from 1 nM to 100 μM using only 10 μL of cocaine 
sample with a 5 minute response time. Due to the nature of aptamer-target binding, which 
is sensitive to external stimuli, it was shown that an increase in temperature from ambient 
to 37°C results in the release of the bound cocaine. Full reusability of the device was then 
demonstrated by multiple tests involving sensing and regeneration following a wash with 
pure buffer and a mild increase in temperature. As the sensor is designed along standard 
microfabrication principles, mass production to reduce manufacturing costs should be 
possible. This represents an improvement over previous aptamer-based cocaine sensors 
as well as a viable alternative to conventional methods of cocaine detection. Further work 
will include possible improvements to the cocaine sensing system, including alternate 
choices of chamber geometries and fluorophore-quencher pairs. 
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Chemical amplification of nucleic acids is most commonly realized with the 
polymerase chain reaction (PCR), in which a DNA molecule, referred to as a template, is 
exponentially duplicated via repeated thermal denaturation and enzymatic replication 
[117]. Bead-based PCR is a variant of the PCR procedure that uses primers (short DNA 
fragments complementary to a specific region of the template) attached to microbeads. 
This procedure results in bead-tethered template DNA duplicates; it is hence an attractive 
analytical tool that simultaneously accumulates signals from DNA-based transducers and 
allows manipulation of DNA itself via solid-phase extraction (SPE) techniques. 
In recent years, bead-based PCR has been used in a variety of applications 
including DNA sequencing, protein screening, and pathogenic DNA detection. For 
example, whole genome sequencing has been demonstrated with reduced cost and assay 
time by using bead-based PCR to facilitate the organization and detection of amplified 
sections of a fragmented E. coli genome [118]. Compartmentalization of DNA in 
emulsions [119] combined with bead-based PCR [120, 121] also provides a method of 
rapidly screening an entire genome for DNA binding proteins [122] and for cell-free 
protein synthesis [123]. In addition, genomic DNA (gDNA) has been detected using 
bead-based PCR [124], or similarly via PCR on nanostructured surfaces [52]. While 
demonstrating the utility of bead-based PCR, these examples primarily rely on 
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conventional instrumentation for reaction control (temperature cycling), involve tedious 
and error-prone manipulation of primer-coupled beads, and require laborious sample pre-
treatment (e.g., for the separation of gDNA from cell lysate) prior to the PCR reaction. 
These limitations are a major hindrance to the widespread use of bead-based PCR.  
Microfluidics technology addresses the limitations of conventional PCR schemes, 
most notably by providing a more rapid and efficient reaction platform. Extensive 
applications of microfluidics to PCR [79-81] have taken advantage of the more efficient 
heat transfer properties to create rapid, miniaturized PCR devices [125] capable of 
detecting as little as a single molecule of DNA [126]. Microfluidics has also enabled 
integrated chip-based systems that perform tasks such as sample pre-treatment and post-
amplification analysis [89-91, 127], further improving reaction speed and test accuracy 
by shifting more operations to the microscale domain. In particular, microfluidic PCR has 
been used to detect gDNA [89, 91, 128, 129], resulting in improvements in sensitivity, 
specificity and turnaround times over other pathogen detection methods, such as cell 
culturing and antibody-based assays. However, these works have almost exclusively 
involved solution-based PCR (i.e., PCR with primers residing in solution), and while 
microfluidics holds the same advantages for solid-phase amplification there are far fewer 
applications of microfluidics to solid-phase PCR implementations such as bead-based 
PCR. Much of the bead-based PCR literature relies upon bead-based PCR in emulsions, 
in which case the emulsions are typically amplified in a conventional thermal cycler [120, 
121, 123, 130-132]. In one relevant investigation reported recently, primers were tethered 
to nanostructured surfaces of a biochip to allow optical detection of human gDNA 
indicative of hemolytic diseases such as autoimmune hemolytic anemia [52]. However, 
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the nanostructures were based on a flat surface, limiting the surface area-to-volume ratio 
and leading to a practically inadequate sensitivity. 
This chapter investigates bead-based PCR on a microfluidic chip by applying it to 
DNA pre-conditioning and detection, as demonstrated by the capture, amplification, and 
detection of trace quantities of a synthetic DNA sequence identical to a repetitive 
segment of the genome of Bordetella pertussis (B. pertussis). Trace DNA is introduced 
into the device microchamber along with PCR reagents and microbeads, and thermally 
cycled using an integrated heater and temperature sensor. The microbeads provide a high 
surface area to volume ratio platform for accumulation of transducing labels, creating a 
rapid, simple method to detect trace amounts of DNA. The bead-based design allows for 
simple integration with other functionalities, including sample purification [133] and 
downstream analysis. Experimental results show that a synthetically generated segment 
of the B. pertussis genome 181 base pairs (bp) in length can be detected in 10 PCR cycles 
(within 15 minutes) at a clinically relevant concentration of 1 pM (approximately 6 × 10
5
 
copies/μL). This approach is then demonstrated to perform integrated DNA capture, 
amplification, detection, and purification in a single microchamber. Bead-based PCR is 
thus shown to be both an effective DNA detection method and a DNA pre-conditioning, 
detection, and analysis system that can be simply integrated into microfluidic devices. 
 
3-2 Materials and Methods 
3-2.1  Bead-Based PCR Principle 
PCR is a biochemical amplification process which uses a thermostable enzyme to 
dehybridize and duplicate template DNA. During a PCR reaction, cyclic changes in 
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temperature cause denaturation of template dsDNA and then hybridization of primers to 
the separated single-stranded DNA (ssDNA) strands. A temperature cycle consists of 
three steps: dsDNA melting (denaturation) at 95°C, primer annealing (hybridization) at 
50 – 62°C, and DNA extension at 72°C. PCR reactions also typically include an initial 
melting step at 95°C (pre-melting) and a final extension step at 72°C. Reagents include 
two sets of primers: reverse primers that hybridize to template ssDNA, and forward 
primers that hybridize to the complementary ssDNA. Extension of these template-primer 
pairs by the thermostable Taq polymerase produces dsDNA consisting of the template 
and its complementary strand. Repeated temperature cycles result in amplification, i.e., 
generation of exponentially increasing duplicate copies of the dsDNA.  
Bead-based PCR is a solid-phase implementation of PCR, in which DNA is 
duplicated while tethered to the surfaces of microbeads in solution. In bead-based PCR, 
one of the two primer sets (typically the reverse primer) is tethered to a bead surface, 
while the untethered (forward) primer can be labeled with a detectable tag (e.g., a 
fluorophore). Bead-bound reverse primers are mixed with template ssDNA, labeled 
forward primers and other reactants (e.g., nucleotides and Taq) in solution, and hybridize 
to template ssDNA molecules. This results in the capture of template DNA by the 
microbeads and is hence effectively a SPE process. This completes the first temperature 
cycle, which produces unlabeled dsDNA. During the second temperature cycle, the 
dsDNA from the previous cycle is denatured, allowing template DNA and fluorescently 
labeled forward primers to hybridize to bead-bound ssDNA (complementary strands of 
the template). Extension then generates labeled duplicates of template DNA hybridized to 
the bead-bound complementary strands. This process is then repeated with further 
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temperature cycles to produce exponentially increasing copies of dsDNA consisting of 
labeled template and unlabeled, bead-tethered complementary strands.  
 
3-2.2  Microchip Design and Fabrication 
The bead-based PCR microchip consists of a microfluidic chamber, which is 
fabricated in the elastomer polydimethylsiloxane (PDMS) and bonded to a glass slide 
with an integrated resistive heater and temperature sensor (Figure 3-1a). The heater has a 
serpentine geometry covering the chamber area as well as a large surrounding area to 
generate a sufficiently uniform temperature field in the chamber, while the resistive 
temperature sensor is located at the center of the chamber area. The cylindrical chamber 
is open to atmosphere and consists of two vertically aligned connected compartments of 
different diameter. The lower compartment contains the aqueous PCR sample, and 
expands to the upper compartment of larger diameter that retains a layer of mineral oil 
over the PCR sample. The entire chamber surface is conformally coated with a layer of 
the polymer Parylene C. The mineral oil and Parylene coating eliminate water 
evaporation that would otherwise occur directly to open air or through the PDMS, while 
minimizing the potential formation of air bubbles. The Parylene also provides a PCR-
compatible surface, which, along with the use of additives such as bovine serum albumin 
(BSA) and Tween, minimizes adsorption of reaction components such as DNA and Taq 
polymerase [134]. 





















Figure 3-1. Device design. (a) The chip consists primarily of a PDMS chamber bonded 
to a glass slide which has been patterned with a micro heater and temperature sensor. Key 
dimensions of the PDMS microchamber have been included in projected top and side 
views (all dimensions in mm). (b) Also shown is the design of an integrated microfluidic 
device, in which weirs retain microbeads in the chamber while beads are exposed to 
streams of buffer or reagents.  
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Devices were fabricated using standard microfabrication techniques. Chrome and 
gold layers (thicknesses: 20 and 200 nm) were thermally deposited onto glass microscope 
slides and patterned using contact lithography and wet etching techniques. Patterning 
generated a 5.67 cm long by 200 µm wide heater having a resistance of approximately 20 
ohms and covering an area of 0.242 cm
2
, and a 1.04 cm long by 40 µm wide resistive 
temperature sensor having a resistance of approximately 30 ohms. The thermal elements 
were then passivated with SiO2 (thickness: 1 μm) formed using plasma-enhanced 
chemical vapor deposition, with openings for electrical connections formed using a 
shadow mask. The SiO2 not only passivates the electrical components, it provides an 
efficient bonding surface for PDMS. To generate PDMS for the microfluidic chambers, 
PDMS prepolymer was mixed 10:1 with a curing agent and poured onto a clean silicon 
wafer, baked for 30 minutes at 75°C, and then peeled from the wafer. Microfluidic 
chambers were defined by puncturing holes in the PDMS using a hole punch. The bottom 
PDMS piece was 1.3 mm thick with a 3.2 mm diameter hole, and the top piece was 1.3 
mm thick with a 4.75 mm diameter hole. The glass substrate and PDMS sections were 
then treated using UV-generated ozone for 10 minutes, and bonded by baking at 75°C for 
30 minutes. During bonding, the PDMS holes were aligned to the center of the integrated 
heater patterned onto the glass slide. The chip was then conformally coated with a layer 
of Parylene C approximately 1 μm in thickness via chemical vapor deposition, with 
scotch tape used to block electrical pads. 
The chip design was also modified to demonstrate integrated microfluidic PCR, 
by incorporation of microfluidic channels enabling bead insertion and retention during 
wash steps (Figure 3-1b). Optical lithography was used to define an SU-8 mold for a 4 
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μL PCR chamber 400 μm in depth and 3.6 mm in diameter. The mold incorporated two 
inlets with flow restrictions limiting the local vertical channel clearance to 20 μm, serving 
as passive weirs to retain microbeads in the chamber, and a third inlet with no weir to be 
used for bead insertion. The microchamber and channels were again fabricated from 
PDMS, and bonded to a glass slide integrated with a resistive heater and temperature 
sensor. 
In addition to designing and fabricating the microchip, the bead-based primers 
were designed to allow rapid and simple operation of the device. Biotin-streptavidin 
coupling was used in this study to attach the reverse primers to the beads, as this bond is 
both strong and formed spontaneously in the presence of both molecules. The reverse 
primers were synthesized with a dual-biotin label at the 5’ end, followed by a spacer 
molecule adjacent to the nucleotide sequence. The dual-biotin moiety minimizes loss of 
signal due to thermal denaturation as investigated in Results and Discussion. Spacer 
molecules provide greater lateral separation between DNA on the beads, reducing 
hybridization issues due to steric hindrance. Synthetically generated template DNA was 
used to obtain controlled, consistent experimental results for characterization of DNA 
detection using bead-based PCR.   
 
3-2.3 Application to Pathogenic DNA Detection 
The bead-based PCR chip is applied to pathogenic DNA detection, demonstrated 
with a DNA sequence associated with B. pertussis. Bordetella pertussis is a gram-
negative bacteria that infects approximately 48.5 million patients (with 300,000 fatalities) 
annually worldwide [135]. While early detection is key to the treatment of this disease, 
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current methods (e.g., cell culturing) for detecting the B. pertussis bacterium take days or 
even weeks of turnaround time [136, 137]. This limitation can be potentially addressed 
by the bead-based PCR microchip, which is designed to allow rapid, sensitive, and 
specific detection of B. pertussis. 
Pathogenic DNA detection using bead-based PCR on a microchip can be 
accomplished as shown in Figure 3-2. Bead-tethered reverse primers on the chip can be 
exposed to a raw sample, such as cell lysate (Figure 3-2a). Pathogenic DNA in the 
sample is then captured and purified onto the beads via its specific hybridization to the 
reverse primers (Figure 3-2b), as demonstrated in previously published work [133]. 
Following capture and purification, template DNA can be mixed on-chip with PCR 
reactants and bead-based PCR of the template DNA can then be performed using 
fluorescently labeled forward primers (Figure 3-2c). This process rapidly generates 
exponentially amplified, fluorescently labeled template copies on microbeads, which can 
be detected by fluorescent microscopy. The use of beads in the detection volume 
generates an enhanced signal-to-noise ratio in comparison to amplification on flat solid 
surfaces [52, 118] due to a significant increase in the fluorophore-coated surface area. 
Finally, the labeled copies of the template can be freed from their bead-bound 
complements by denaturation and eluted into pure buffer for further analysis, while the 
bead-bound complementary strands (cDNA) can be retrieved from the chip and stored as 
cDNA libraries [138] (Figure 3-2d).  
 
















Figure 3-2. Integration of microchip bead-based PCR. Primer-coated beads permit 
separation of DNA from impurities (a,b), and amplification produces a fluorescent signal 
on the bead surfaces (c) via microchip PCR. The beads then act as a mechanism for either 
storage or collection and analysis of ssDNA following thermally-induced dehybridization 
and release (d). 
 
3-2.4 Materials, Reagents, and Experimental Procedures 
For detection of DNA associated with B. pertussis, the following materials and 
reagents were used. All DNA was obtained in lyophilized form from Integrated DNA 
Technologies, Coralville, IA. The primers are designed as a PCR assay for determination 
of B. pertussis infection [139, 140]. The DNA sequences used are as follows. Forward 
primer: 5’-FAM-Spacer-GAT TCA ATA GGT TGT ATG CAT GGT T-3’, reverse 
primer: 5’-Double Biotin-Spacer-TTC AGG CAC ACA AAC TTG ATG GGC G-3’, and 
template: 5'-GAT TCA ATA GGT TGT ATG CAT GGT TCA TCC GAA CCG GAT 
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TTG AGA AAC TGG AAA TCG CCA ACC CCC CAG TTC ACT CAA GGA GCC 
CGG CCG GAT GAA CAC CCA TAA GCA TGC CCG ATT GAC CTT CCT ACG 
TCG ACT CGA AAT GGT CCA GCA ATT GAT CGC CCA TCA AGT TTG TGT 
GCC TGA A-3'. The forward primer has been modified with the fluorescent label 
carboxyfluorescein at the 5’ terminus, while the reverse primer incorporates a dual-biotin 
modification at the 5’ end. Both molecules contain an inert spacer molecule between the 
5’ modifications and the nucleotide sequence. PCR was performed using Taq enzyme, 
deoxynucleotide triphosphates (dNTPs), and PCR reaction mixture containing 
appropriate buffers (Promega GoTaq Flexi PCR Mix). Reverse primers were 
immobilized onto streptavidin-coated polymer-based microbeads (Thermo Scientific 
Pierce Protein Research Products Ultralink Streptavidin Resin) averaging 80 μm in 
diameter. Concentration and purity measurements of DNA samples were conducted using 
UV/VIS (Thermo Scientific Nanodrop). Materials used in microfabrication included 
photoresist (Rohm & Haas Electronic Materials S1818, Microchem SU-8 2000), PDMS 
prepolymer (Dow Corning Sylgard 184), and Parylene C prepolymer (Kisko diX C).  
PCR reaction mixture for B. pertussis DNA detection experiments was prepared 
as follows. Each lyophilized DNA sample was suspended in deionized H2O and diluted to 
the desired concentration. The PCR mixture consisted of the following: 5 PCR Buffer (2 
μL), 25 mM MgCl2 (0.6 μL), 10 mM dNTPs (0.4 μL), 50 μg/mL BSA (0.4 μL), 5% (by 
volume) Tween 20 (0.1 μL), microbeads (0.5 μL), water (4.1 μL), 25 μM forward primer 
(0.4 μL), 25 μM reverse primer (0.4 μL), and enzyme (0.1 μL). The ingredients were 
mixed with template DNA (1 μL of synthetic template DNA with a concentration range 
of 1 aM to 100 pM) without the enzyme and the mixture was then degassed at -0.4 psi for 
  54 
  
30 minutes in a darkened container (to prevent photobleaching of the fluorophore label). 
Testing in the PCR device also occurred under an enclosure to prevent excess light from 
reaching the DNA. Following degassing, enzyme was added to the mixture and the 10 μL 
PCR sample was pipetted into the chip, followed by 30 μL of mineral oil. During 
experiments with the integrated device, PCR reaction mixture was degassed without 
primer-coated beads. These were inserted into the device, followed by template DNA, 
after which the DNA and beads were allowed to incubate for 10 minutes. This solution 
was then removed (with the beads retained by the weirs), and the PCR reaction mixture 
was introduced. The temperature of the sample was then cycled using the Labview 
control program to implement the reaction. 
During testing, the reaction temperature was controlled using a Labview program 
that utilized sensor feedback to maintain a constant temperature field inside the PDMS 
chamber. A desktop power supply (Agilent E3631A) and a digital multimeter card (NI 
PCI-4060) provided electrical power and resistance measurements. An inverted 
fluorescence microscope (Nikon Diaphot 300) was used for all fluorescence 
measurements, while an attached digital camera (Pixelink PL-B742U) was used to record 
images of the excited fluorescent field. The microscope contains a dichroic mirror which 
attenuates light above the peak absorption wavelength of the fluorophore (approximately 
494 nm) during excitation and passes the higher emission wavelengths (which peak at 
approximately 512 nm) through the objective for observation and measurement. 
Following PCR, the sample was pipetted to a darkened 0.5 mL microcentrifuge 
tube. Beads were washed 6 times with 1× SSC buffer to remove excess labeled primers. 
Bead washing was implemented by mixing the sample with buffer, allowing the beads to 
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settle via gravity, and removing the supernatant with a pipette. A five microliter aliquot 
of each test sample was pipetted into an individual 3.2 mm diameter PDMS well on a 
glass slide, and was observed using the fluorescent microscope. During integrated device 
testing, microbeads were washed by passing buffer through the chamber while being 
retained by the weirs (Section 3-2.2) prior to fluorescent measurement. The microscope 
was kept in an enclosure to prevent ambient light from interfering with the measurements 
or bleaching the fluorescent labels. The samples were briefly excited with light using the 
fluorescent light source and the resulting emission was recorded using the CCD camera 
microscope attachment. Camera exposure times were optimized based on fluorescent 
signal intensity during device characterization (Sections 3-3.1 and 3-3.2) to maximize the 
signal-to-noise ratio, defined here as the ratio of the measured fluorescence intensity to 
the intensity of background fluorescence. While this did not guarantee a single baseline 
signal intensity during the tests, the use of relative fluorescence intensity allowed 
consistent interpretation of the experimental results. Digital images were analyzed using 
ImageJ software. 
 
3-3 Results and Discussion 
We tested the ability of the fabricated device to detect pathogenic DNA via the 
bead-based polymerase chain reaction. The device was first calibrated to determine 
physical characteristics such as the temperature coefficient of resistance (TCR) of the on-
chip temperature sensors, and the thermal response of the PCR chamber. Following 
physical characterization, the effects of experimental parameters on bead-based PCR 
results were investigated. By varying the time and temperature of individual PCR steps, 
  56 
  
reactant concentrations, and bead concentration their impact on signal intensity was 
examined. Then, the ability of the device to detect pathogenic DNA was tested by 
determining the minimum detectable concentration of DNA and the minimum assay time. 
Finally, the bead-based PCR method was demonstrated in an integrated microfluidic 
device and shown to be able to capture, amplify, detect, and release single-stranded DNA. 
 
3-3.1 Physical Characterization of the Device 
The resistive heater and sensor were first characterized to enable accurate on-chip 
temperature control. The chip was placed in a temperature-controlled environmental 
chamber and its temperature varied. Chamber temperatures were measured using a 
platinum resistance temperature detector probe (Hart Scientific 5628) and on-chip 
resistances were measured with a digital multimeter (Agilent 34420A). Resistance 
measurements of temperature sensors indicated a linear relationship between resistance 





(see Appendix 1). The heater was found to have a resistance of approximately 20 Ω. 
The accuracy of on-chip temperature measurements and the heating rate of the 
chip were then tested. A 1.5 mm diameter insulated K-type thermocouple probe (Omega 
Engineering) was inserted into the sample chamber along with a pure water sample. The 
chamber temperature was then controlled (heated cyclically) as would occur during a 
typical PCR test, but without the amplification reagents. According to the time course of 
temperature obtained during this control test (Figure 3-3), the chip achieves target 
temperatures with minimal overshoot. The device exhibited an average time constant of 
heating (based on an exponential fit) of approximately 1.4 s. In addition, the 
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thermocouple readings agreed with the temperature setpoints to within plus or minus 
0.5 °C (data not shown). This indicates that the chamber temperature can be controlled to 



























Figure 3-3. Temperature history of a typical PCR cycle. 
 
The effects of test conditions, such as ambient light and temperature, on test 
results were also investigated. Biotin-streptavidin binding was chosen as a simple and 
effective alternative to covalent methods for DNA immobilization [120, 141], however 
streptavidin molecules may denature as a result of the elevated temperature necessary to 
dehybridize DNA [142]. Dual-biotin functionalization has been implemented in previous 
work to counteract this effect [120, 121], however no quantitative data was reported to 
support the effectiveness of this technique. To generate such data, temperature cycling 
equivalent to typical PCR testing was performed on linkages between streptavidin and 
dual-biotin labeled DNA. Beads coated with streptavidin were mixed with 1 μM dual-
biotin labeled primers and an equal concentration of fluorophore-labeled complementary 
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strands. The solution was subjected to temperature cycling, returned to room temperature, 
and washed to remove any DNA in solution. In Figure 3-4, the fluorescent intensity is 
shown for untested beads (zero temperature cycles) and for beads subjected to 10, 20, 30, 
or 40 rounds of temperature cycling. Intensity, measured in arbitrary fluorescence units 
(afu), did not vary from baseline (zero temperature cycles) as a result of temperature 
cycling. This indicates that the concentration of DNA on the bead surfaces changes 
negligibly as a result of the PCR process, producing minimal error as a result. Another 
potential source of error is the effect of ambient light on the fluorescent labels. This effect, 
known as photobleaching, was found to be negligible for this experimental setup in 
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Figure 3-4. Effect of temperature on fluorescence measurements, n = 3. The negligible 
change in fluorescence intensity indicates that temperature cycling does not degrade dual 
biotin functionalization and hence does not affect concentration of DNA at bead surfaces. 
Error bars indicate one standard deviation from the mean. 
 
3-3.2 Effects of Experimental Parameters on Bead-Based PCR 
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The effects of experimental parameters on bead-based PCR were studied to 
optimize the ability of the device to detect DNA. During a series of PCR reactions, 
parameters were varied individually and the results studied to determine the parameters 
that would generate maximum signal intensity, thus lowering the detection limit of the 
device.  
Control for Effects of Bead-Based Amplification. First, solution-based PCR 
(i.e., excluding microbeads) was performed to confirm device calibration and sequences 
of both DNA primers (25 bases) and template (181 bases). Following amplification, gel 
electrophoresis was performed and results indicate that a strand of the expected length 
(181 bp) was produced (Figure 3-5a). This confirms that the device temperature control is 
accurate enough to perform PCR, and that the DNA has been properly designed and 
synthesized. This test was then repeated using bead-based PCR and produced identical 
results (Figure 3-5b) following DNA recovery from the beads via biotin-streptavidin 
denaturation in a 95°C formamide bath. Following ethanol precipitation of the DNA and 
resuspension in distilled H2O, gel electrophoresis was performed. These results indicate 
that coupling the reverse primers to the beads does not cause improper DNA 
amplification (such as the generation of spurious products). In addition to the comparison 
with solution-based PCR, bead-based PCR tests were conducted with smaller reaction 
volumes (5 μL), and this was not found to influence the average fluorescent signal 
intensity following amplification. 
 













   
Figure 3-5. Gel electrophoresis analysis of PCR tests using the 181 bp B. pertussis DNA 
amplification chemistry. Gel (a) displays the results of a solution-based test, and gel (b) 
shows the results of a bead-based test. In both gels, lane (i) is a sample of PCR products 
mixed with loading buffer, and lane (ii) is a 100 bp ladder (dsDNA for length reference). 
Arrow indicates direction of DNA movement, with smaller strands migrating faster. 
 
Determination of Optimum Magnesium Concentration and Dwell Time. 
Optimum magnesium concentration was determined to be 1.5 mM, consistent with 
typical MgCl2 concentrations for PCR studies (see Appendix 1) [144, 145]. A series of 
tests also determined that a consistent 20 s dwell time, or time spent at each temperature 
setpoint during a PCR cycle, would produce DNA most efficiently (see Appendix 1). 
Determination of Optimum Annealing Temperature. The effect of annealing 
temperature on the concentration and length of DNA generated during PCR was then 
studied. The annealing temperature affects the hybridization of the primers to the 
template DNA; a higher annealing temperature typically results in more specific 
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hybridization (less erroneous hybridization of a primer to an unspecified DNA sequence) 
but less total hybridization of DNA (and therefore less product DNA after PCR) [144, 
145]. A series of bead-based PCR tests was conducted using the B. pertussis primer set in 
which the annealing temperature was varied. The results indicated that fluorescent 
intensity of the beads following PCR remained approximately consistent (Figure 3-6). 
Large variation in individual test results was observed for tests with an annealing 
temperature of 54°C; it is possible that non-specific annealing at this temperature causes 


































Figure 3-6. Effect of annealing temperature on fluorescent intensity after bead-based 
PCR, n=3, with error bars representing one standard deviation from the mean. 
 
The annealing temperature test was then repeated with conventional solution-
based PCR, and the results were analyzed using gel electrophoresis (Figure 3-7). Results 
indicated no amplification at 52°C, very close to the temperature at which a high degree 
of variability was observed in the bead-based tests. As it appears that this range of 
annealing temperatures produces sporadic results, a higher annealing temperature was 
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chosen for future testing. The results from the solution-based experiments suggested that 
an annealing temperature of 58°C minimized generation of primer-dimers, a type of non-
specific amplification which occurs when two primers hybridize and are extended during 
PCR. Bead-based PCR results cannot discern the length of generated DNA, so non-
specific amplification represents a source of false positive readings during DNA 
detection. This effect must be inhibited to maximize sensor specificity. The optimized 
PCR cycle parameters (cycle times and temperatures) have been summarized in Table 1. 
 






Figure 3-7. Gel electropherogram showing effects of annealing temperature on amplified 
DNA following solution-based PCR.  
 
Table 3-1. Summary of PCR cycle parameters. 
Stage Temperature (°C) Dwell Time (s)
Pre-melting 95 60
95 20
Thermal Cycling 58 20
72 20
Post-extension 72 180  
 
Investigation of Effects Bead Concentration on Bead-Based PCR. Next, the 
bead-based PCR detection device was optimized with respect to the concentration of 
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beads in the reaction mixture. The presence of a solid surface in bead-based PCR 
introduces steric and geometric effects, affecting the reaction efficiency [141, 146]. 
Previous studies of solid-phase amplification [147-149] focused on maximizing the final 
concentration of DNA, however the primary concern of this study is detection of DNA. 
The concentration of microbeads in the reaction mixture was therefore investigated and 
optimized to produce the greatest fluorescent signal. To test the effects of bead 
concentration on fluorescent signal intensity, bead-based PCR reactions were performed 
using optimized conditions (58°C annealing temperature, 1.5 mM MgCl2 concentration, 
10 pM template concentration) and three different concentrations of beads (Figure 3-8). It 
can be seen that approximately 200 beads/μL generates the most intense fluorescent 
signal on the beads, with a significant decrease in signal intensity at either a lower or a 






























Figure 3-8. Effect of bead concentration on fluorescent bead intensity following PCR, n 
= 3, with error bars representing one standard deviation from the mean. Results indicate 
there is a concentration of microbeads in the reaction mixture which optimizes signal 
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intensity following the PCR reaction. The students’ t-test confirms that the 200 beads/μL 
result is differentiable from the other results, p < 0.11%. 
 
The sharp peak in Figure 3-8 can be explained by the relationship between the 
concentration of microbeads in the reaction mixture and the total surface area of the 
surface-based PCR reaction. At higher concentrations of microbeads the fluorescently 
labeled product DNA is spread across a larger number of beads. The greater surface area 
results in a weaker fluorescent signal because the signal strength is proportional to the 
surface density of the fluorescent labels. On the other hand, a lower concentration of 
beads does not imply a higher surface concentration of DNA. At these bead 
concentrations, the greater density of reverse primers limits the reaction by steric 
hindrance between molecules at the bead surfaces. As noted in previous studies, 
increasing proximity of reverse primers to one another on solid surfaces can hinder the 
ability of DNA in solution to hybridize to the bead-bound primers [148, 149]. In addition 
to steric hindrance, the increasing density of the fluorophores on the bead surfaces may 
result in quenching to due to proximity of other fluorophores and nucleotides, which are 
known to inhibit fluorescence [150]. Alternatively, a lack of microbeads in the reaction 
will cause some reverse primers to remain in solution, as each bead can support a limited 
number of primers. The competition of these in-solution primers for the template DNA 
and the lower efficiency due to steric hindrance account for the drop in signal intensity at 
lower bead concentrations. Figure 3-8 shows that there is a ninefold decrease in signal 
intensity from 200 to 20 beads/μL, indicating that bead concentration strongly influences 
the ability of the sensor to detect DNA. Based on the results, in the future it may be 
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possible to predict the optimum concentration of beads for a DNA sensor using bead-
based PCR. 
 
3-3.3 Investigation of Detection Sensitivity 
Finally, the device was tested to determine its ability to detect synthetic gDNA. 
Detection criteria included the limit of detection (the smallest concentration of DNA that 
could be detected) and the number of PCR cycles necessary for detection. The limit of 
detection of the device was investigated by performing a series of PCR reactions while 
changing the concentration of template DNA in the reactants. Concentrations ranging 
from zero templates to 1 pM (approximately 6 × 10
5
 copies/μL) were tested. PCR 
reactions were run for 10 cycles (approximately 15 minutes) using the optimized test 
conditions discussed above (200 beads per microliter, 20 s dwell times, 58°C annealing 
temperature, and 1.5 mM MgCl2). As can be seen in Figure 3-9, concentrations of 0.1 pM 
and less produced an increase in fluorescence above the zero template reaction. As 
indicated by the error bars, however, this increase is within one standard deviation of the 
average fluorescence for the zero template tests. Zero-template amplifications produce a 
fluorescent signal because non-specific amplification products such as primer-dimers are 
detected in addition to properly amplified DNA. This effect is investigated further in the 
following discussion of signal intensity versus cycle number. A template concentration of 
1 pM, however, produced a signal distinguishable from the zero template control, as 
determined by the student’s t-test with a 95% confidence level. These results are 
comparable to those obtained recently using a microfluidic quantitative PCR device [151]. 
In addition, this detection limit is orders of magnitude smaller than limits reported in 
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similar studies using PCR with electrochemical labels [124] or optical detection on a flat 
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Figure 3-9. Investigation of DNA detection limit. Fluorescent intensity of beads 
following the PCR reactions is plotted against concentration of templates in the reaction 
mixture. Error bars indicate one standard deviation from the mean of three experiments 
(n=3), and the reaction with zero templates (control) and a 1 pM template concentration 
(the detection limit) is differentiable with a probability of greater than 95%, according to 
the students’ t-test. 
 
In addition to measuring the detection limit of the device, the relationship 
between signal intensity and the number of PCR cycles performed prior to detection was 
also investigated. It was possible that increasing the assay time (the number of PCR 
cycles) would improve the signal strength, thereby lowering the detection limit. For this 
investigation, bead-based PCR reactions were performed as discussed in the previous 
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section, but a 1 pM (approximately 6 × 10
5
 copies/μL) concentration was consistently 
used and the number of PCR cycles was varied. As can be seen in Figure 3-10 signal 
intensity at 10 cycles is well above background levels and increases from 10 to 30 cycles. 
There is a slight decrease in signal from 10 to 20 cycles that can possibly be explained by 
several effects associated with solid-phase amplification. Previous studies have noted a 
number of detrimental effects, such as non-specific amplification between two surface-
bound primers or creation of sterile (incomplete) molecules, both of which could then 
reverse themselves with further amplification [141, 148]. In addition to amplification of a 
1 pM sample, a control sample with no template DNA was also amplified and the results 
are displayed in Figure 3-10. The control signal shows a linear increase in intensity, but 

































Figure 3-10. Relationship between signal intensity and the number of PCR cycles used 
during amplification of a 1 pM sample. Mean values from multiple tests (n = 3) are 
shown, error bars indicate standard deviation.  
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These results have two important indications for the design of a bead-based PCR 
DNA detection test. First, the zero template control signal remains below that of the 1 pM 
signal, indicating that non-specific amplification does not impair the specificity of the test. 
Second, that increasing the number of PCR cycles may not improve sensitivity. While the 
fluorescent signal intensity increases overall with increasing numbers of PCR cycles, the 
control signal increases as well. If this signal is considered to be background, the signal 
to background ratio as shown in this graph decreases with increasing numbers of PCR 
cycles, from 3.9 at 10 cycles to 2.2 at 30 cycles. This may be attributed to the continued 
generation of non-specific amplification products when amplifying with no template 
molecules [152]. As discussed in Section 3.2, the decrease in fluorescence may also be a 
result of quenching of fluorophores at the bead surfaces due to the proximity of other 
fluorophores and DNA. It appears that the signal does not mimic the exponential nature 
of PCR amplification; while data from the literature [121, 142, 153] and control tests 
(Figure 3-4) showed that this was not a result of loss of DNA from the beads at elevated 
temperatures, the exact nature of the relationship between fluorescent signal intensity and 
surface density of DNA needs to be further investigated.  
 
3-3.4 Integrated Bead-Based PCR Operation  
To demonstrate the utility of the bead-based PCR scheme in an integrated device, 
DNA capture, amplification, detection, and purification was performed in a single 
microfluidic chamber. A 5 μL volume of microbeads (concentration: approximately 200 
beads/μL) was inserted into the microchamber (Figure 3-11a), and 10 pM template DNA 
(approximately 6 × 10
6
 copies/μL) was then inserted and allowed to incubate for a period 
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of ten minutes (Figure 3-11b). This solution was then removed and PCR reaction mixture 
introduced, at which point the integrated heaters and sensors were used to cycle the 
chamber temperature to effect 10 cycles of PCR. Following amplification, the reaction 
mixture was removed by washing with pure buffer, leaving only beads coated with 
fluorescently-labeled DNA in the microchamber (Figure 3-11c). Analysis of the 
fluorescent micrograph indicated that the beads fluoresced with an intensity of 75.9 afu, 
well above the detection limit determined in previous experiments (Section 3-3.3). The 
chamber temperature was then raised to and maintained at 95°C for 5 minutes, denaturing 
the bead-bound ssDNA and eluting it into a pure buffer solution. UV/VIS spectroscopy 
confirmed that the eluent contained 163.6 ng/μL ssDNA. A fluorescent micrograph of the 
microbeads that remained in the microchamber (not shown) confirmed that product 
ssDNA had indeed been removed from the beads. These results illustrate that the use of 
bead-based PCR can enable the design of a highly integrated microchip for DNA 
purification and detection, with precise control of buffer conditions during on-chip 
procedures. In the future, devices using this approach could easily be automated to 
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Figure 3-11. Micrographs of the microchamber illustrate the process of integrated 
microfluidic bead-based PCR. In (a), a brightfield micrograph shows a microchamber in 
which beads have been inserted into the chamber and a DNA solution is being introduced 
(fluid flowing from top to bottom). In (b), the DNA solution has been introduced, and 
template DNA is being captured from the solution onto bead surfaces by bead-bound 
reverse primers. Following PCR cycling, and washing with buffer, the fluorescent 
intensity of the microbeads was measured with minimal background fluorescence (c). 
 
3-4 Conclusions 
There is a strong need for innovative methods for DNA manipulation and 
detection to enable improved molecular biology analysis and diagnostics. Aiming to 
address this need, this chapter has demonstrated a microchip that is capable of amplifying 
and detecting trace amounts of DNA via bead-based PCR amplification and fluorescent 
labeling and detection. The device uses dual-biotin labels on the reverse primers and 
carboxyfluorescein labels on the forward primers to produce labeled dsDNA on the 
surface of streptavidin-coated microbeads. Positive detection of 1 pM of template DNA 
was achieved in only 10 PCR cycles within 15 minutes. This is similar to other PCR 
devices making use of fluorescent probes, in which similar starting template 
concentrations are typically detected in a comparable number of PCR cycles [151].  
In contrast to the previous devices that have attempted integration of sample pre-
treatment with amplification for isolation of gDNA from lysate [89, 91, 127], this 
approach exploits bead-based amplification and detection, and is hence potentially 
simpler and more efficient. Microfluidic PCR is capable of detecting as little as a single 
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DNA molecule, [126], and results have shown that the bead-based amplification process 
detects clinically relevant DNA concentrations and allows for single-chamber integration 
of amplification and detection to upstream and downstream processes that may have 
incompatible buffer requirements. While making use of polymer microbeads and 
streptavidin-biotin conjugation for simplicity, this design can easily be adapted to the use 
of other types of micro- or nanoscale beads (e.g., magnetic beads) as well as covalent 
attachment schemes that suit specific DNA amplification and analysis needs.  
This approach could be extended in the future to include, for example, the 
improvement of the test specificity and signal to background ratio by generating primer 
sets that maintain specificity to a target genome while decreasing primer-dimer creation 
by minimizing affinity between the primers. This may minimize assay time by increasing 
the signal-to-noise ratio and reducing the number of PCR cycles necessary to attain 
detection. In addition, primer-coated beads could be used as a solid-phase extraction 
matrix for gDNA samples in lysate mixtures [133], demonstrating more complex 
protocols in relatively simple microfluidic devices. Thus, this approach can potentially 
lead to miniature clinical diagnostic systems with rapid sample-in, answer-out pathogen 
detection capabilities. 
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Aptamers are single-stranded oligonucleotide or peptide molecules that express 
binding affinity for a target molecule. With a wide range of possible applications from 
sensing [154] to therapeutics [46], the use of aptamers has been exploding in recent years. 
Aptamers are similar in function to antibodies, and as a result they are readily applicable 
in a wide range of fields [155]. Unlike antibodies, however, aptamers are synthetic, 
developed in vitro, and subject to less biodegradation [27]. Once an aptamer sequence is 
isolated, it can be consistently and rapidly reproduced with a wide variety of chemical 
modifications tailored to the desired application. The primary hindrance to the more 
widespread use of aptamers is the resource- and time-intensive nature of the in vitro 
protocol for discovering binding sequences. 
That protocol, known as SELEX or Selective Evolution of Ligands by 
EXponential Enrichment, primarily consists of partitioning target-binding strands from 
unwanted nonbinding oligonucleotides, followed by their chemical amplification and 
repetition of this process several (10 – 15) times (Figure 4-1). SELEX typically requires 
weeks or months of dedicated work on the part of trained scientists, as well as a 
significant quantity of expensive reagents. Conventional partitioning methods, such as 
column- and nitrocellulose fiber-based separation have limited separation efficiency, 
contributing to the time necessary to complete the process. In addition, the repeated 
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amplification steps coupled with all of the necessary pipetting and analysis makes the 
SELEX process expensive and prohibitively time-consuming. A method for rapid 
isolation of aptamer sequences would greatly benefit fields such as aptamer-based 
therapeutics and sensing, by allowing scientists to more quickly and easily generate 
aptamers against potential targets [62]. 
 
(a) Oligomer Library
(b) Selection (c) Separation
(d) Amplification(e) Collection
 





 nucleic acids with randomized sequences (a) is introduced to target molecules (b). 
During selection, unwanted non-binding and weakly bound nucleic acids are separated 
from strongly bound aptamer candidates (c) which are then chemically amplified (d). 
Single-stranded nucleic acids are then separated from the amplified double strands prior 
to repetition of the process (e). 
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Recent work has demonstrated that aptamers can be rapidly isolated by using 
microfluidic technology to partition target-binding aptamers from randomized libraries. 
Microfluidic chips offer much greater surface area to volume ratios than conventional 
devices, which benefits surface-based reactions such as the selection of oligonucleotides 
binding to surface-bound target molecules. For example, using a continuous flow of 
target-conjugated magnetic microbeads in a microchannel, aptamers with nanomolar 
dissociation constants (KD) have been developed with only a single round of selection 
and amplification [2]. This technology has not only sped up aptamer isolation, but 
allowed the development of aptamers with lower dissociation constants [83] and more 
customized binding traits [85]. Similarly, it has been demonstrated that capillary 
electrophoresis (CE) can be applied to separation of target-binding oligonucleotides to 
generate aptamers with specific values of KD and other thermodynamic parameters [95, 
96]. While these and other advances [92, 156] are promising, they focus only on the 
selection step of the SELEX process. Despite a significant field of literature that has 
demonstrated integration of amplification with a variety of other functions [157], efforts 
towards developing integrated SELEX microchips with both selection and amplification 
are still at an early stage. Current integrated SELEX prototypes are inadequate in areas 
such as miniaturization [1] and process control [87]. 
We have developed a fully integrated microchip for isolation of temperature-
specific target-binding oligomers. The microchip makes use of a bead-based protocol for 
both selection and amplification that permits complete control over buffer and 
temperature conditions. Target-coated microbeads provide a means of surface-based 
selection in a microchamber, and primer-coated microbeads act as a surface for solid-
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phase capture and amplification of candidate binding sequences. The device developed in 
this chapter is shown to be capable of integrated selection and amplification, enriching a 
randomized library to express temperature-dependent binding affinity to a target 
molecule, human immunoglobulin E (IgE). Analysis of cloned sequences from the 
enriched library showed an improvement to 25-66% agreement among the randomized 
sequence region. Operation of selection and amplification occurred on-chip with minimal 
external user intervention; this eliminated error-prone pipetting steps, reduced reagent use, 
and decreased the overall process time from several hours to just a single hour. The 
capability of the bead-based approach was thus demonstrated to allow a highly efficient 
isolation of target-binding oligomers in an integrated microfluidic chip. 
 
4-2 Materials and Methods 
4-2.1 Integrated Temperature-Specific Bead-Based Microfluidic Selection 
 The “selection” step of SELEX is the process by which randomized nucleic acids 
are exposed to the target molecule, and desired binding strands are partitioned from 
undesired nonbinders. Typically, selection procedures can be described as either “in-
solution” or “solid phase,” depending on the location of the target molecules during the 
process. In the design discussed in this chapter, target molecules are immobilized on a 
solid phase, via covalent attachment to polymer microbeads. These microbeads are 
inserted into the chip and held in place via flow restrictions (weirs). Selection is then 
performed by flowing solutions of library and buffer through the bead-packed chamber, 
while maintaining the chamber temperature via on-chip closed-loop control. Solutions of 
randomized oligomers (library) are exposed to the beads, allowed to incubate, and then 
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removed via washing. Nonbinding oligomers are then removed by washing with pure 
buffer, and the stringency of the selection can be controlled by varying wash conditions 
such as buffer volume and flowrate. This approach allows complete control over ambient 
selection conditions, including pH, buffer conditions, and temperature, giving the 
experimenter a high degree of control over final aptamer binding affinity. On a 
microfluidic chip, solid-phase selection protocols can lead to enhanced selection 
efficiency due to the high surface area to volume ratios associated with microscale 
designs. In addition, the immobilization of the target molecule simplifies intermediate 
steps in the protocol, such as changing buffers between selection and amplification. This 
promotes simplicity of chip design further enabling the integration of selection in an 
isolation microchip. 
 
4-2.2 Integrated Bead-Based Polymerase Chain Reaction 
 During selection, aliquots of buffer wash over immobilized target molecules, 
removing either unwanted nucleic acids or candidate aptamers. These samples are then 
chemically amplified, to provide an indication of selection efficiency and/or to allow 
further processing, including cloning or further rounds of isolation. As with selection, 
proper temperature and buffer conditions are crucial for efficient amplification. In this 
design, polymer microbeads coated with reverse primers are used to generate a surface 
for specific DNA capture and amplification. As described in a previous publication [158], 
in bead-based PCR the immobilized reverse primers capture ssDNA via hybridization. 
Reagents necessary for amplification can then be introduced into the chamber and the 
temperature cycled to generate exponential copies of the captured template DNA. A 
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crucial aspect of this design is its insensitivity to the input and output buffer conditions; 
the microbeads can capture and release the DNA in a wide range of buffer conditions, 
simplifying integration of the amplification step in a SELEX microdevice.  
Bead-based PCR has the additional advantage of acting as a platform for 
concentration of fluorescent signals that can be incorporated into the DNA structure 
during amplification. In this implementation, forward primers incorporate a 
carboxyfluorescein moiety at the 5’ terminus. As PCR progresses and forwarded primers 
are incorporated into bead-bound dsDNA, more labels accumulate on the bead surfaces 
and can be detected by fluorescent optical microscopy. Given identical amplification 
reactions (number of temperature cycles, reagent concentration, etc.), the fluorescent 
signal intensity is then an indicator of initial template concentration. Generating PCR 
“profiles” by performing this procedure with agarose gel electrophoresis is an analysis 
used during conventional SELEX to investigate errors associated with DNA elution or 
selection efficiency. Alternatively, by calibrating fluorescent intensity to concentration of 
DNA following amplification and elution, the fluorescent intensity of the microbeads can 
indicate if the amplification reaction has produced enough DNA for downstream 
processing. 
 
4-2.3 Design and Fabrication of Chip, Library, etc. 
 The aptamer isolation chip consists primarily of two PDMS microchambers for 
selection and amplification, respectively, on a glass substrate (Figure 4-2). Between these 
two chambers is a serpentine microchannel that acts as a passive mixer. On-chip flows 
are pressure driven, with no combination of flow path and average flowrate (between 1 
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and 10 μL/min) generating a pressure drop greater than 0.5 psi prior to bead introduction. 
Flowrates for the bead-packed chambers were calculated as in the relevant previous work 
[49] and also found to produce negligible pressure drop. The entire chip is coated with 











Figure 4-2. Plan view of the integrated microchip, primarily consisting of microfluidic 
selection and amplification chambers with integrated resistive heaters and temperature 
sensors. 
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 The selection chamber is a 4 μL PDMS cuboid microchamber 400 μm tall with 
2.3 mm sides. The chamber is placed over chrome/gold resistors which generate a 
sufficiently uniform temperature field and provide temperature measurements via a 
resistance-temperature relationship. The heater is 3.145 cm long by 300 μm wide, 200 nm 
thick with a nominal resistance of 20 ohms. The temperature sensor is 0.55 cm long by 40 
μm wide, 200 nm thick with a nominal resistance of 100 ohms. The chamber has one 
inlet 400 μm tall for insertion and removal of target-coated microbeads. Two more inlets 
on opposite sides of the chamber are approximately 10 μm tall, allowing fluid flow while 
act as passive flow restrictions (weirs) to retain the microbeads which are approximately 
100 μm in diameter. 
 The amplification chamber is a 4 μL cylinder, 400 μm tall with an 1800 μm radius. 
Two inlets are 400 μm tall, allowing insertion of microbeads, and one is a 10 μm passive 
weir. As with the selection chamber, chrome/gold resistors beneath the chamber act as an 
integrated heater and temperature sensor. The heater is 4.635 cm long by 300 μm wide, 
200 nm thick with a nominal resistance of 60 ohms. The temperature sensor is 0.8 cm 
long by 40 μm wide, 200 nm thick with a nominal resistance of 120 ohms. 
 The microchip is fabricated using PDMS microchannels on a glass substrate using 
contact lithography. Positive lithography using S1800 series (Dow Chemical, Newark 
DE) photoresist and wet etching defines patterns for resistors and contact pads on a gold-
coated glass substrate. These are then passivated with a 1 μm coating of SiO2 generated 
using plasma-enhanced chemical vapor deposition (Oxford Instruments, Concord MA), 
with pieces of silicon used as shadow masks to define openings for electrical contacts. 
Negative lithography using SU-8 2000 (Microchem, Newton MA) photoresist on silicon 
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wafers defines molds for PDMS microchannels. PDMS prepolymer (Robert McKeown, 
Somerville NJ) is then mixed at a 10:1 ratio of base to curing agent, poured over the 
molds, and heater at 75°C for 25 minutes to generate PDMS microchannels and chambers. 
The PDMS microchannels are then bonded to the glass substrate following 10 minutes of 
exposure to UV-generated ozone (Uvocs, Lansdale PA) and heated to 75°C for 30 
minutes to complete the bonding. Finally the entire chip is coated with Parylene C via 
chemical vapor deposition (Specialty Coating Systems, Indianapolis IN), with scotch tape 
used to define openings for electrical contacts. 
 Target molecules used for this aptamer isolation protocol were human 
immunoglobulin E (IgE), an antibody associated with allergic response. The randomized 
library is an 80-base DNA oligomer consisting of a 40 base central randomized region 
flanked by two 20 base priming regions. The buffer used for selection was phosphate 
buffered saline modified (PBSM) with 1 mM MgCl2. The library/buffer system was 
designed based on previous work targeting IgE for development of a temperature-
sensitive aptamer [33]. 
 
4-2.4 Materials 
 The following materials were used for the microchip aptamer isolation procedure. 
Human IgE was purchased from Athens Research, Athens, GA. All DNA was obtained in 
lyophilized form from Integrated DNA Technologies, Coralville, IA. The library is an 
80mer ssDNA oligomer consisting of a 40 base randomized region flanked by two 20 
base known priming regions. The purchased library sequence is as follows: 5’ – C TAC 
CTA CGA TCT GAC TAG CNN NNN NNN NNN NNN NNN NNN NNN NNN NNN 
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NNN NNN NNN NNG CTT ACT CTC ATG TAG TTC C– 3’. The forward primers 
used were 5’ – C TAC CTA CGA TCT GAC TAG C – 3’, with or without a 5’ 
carboxyfluorescein modification. The reverse primers used were 5’ – G GAA CTA CAT 
GAG AGT AAG C – 3’, with a 5’ dual biotin attachment. In each case an inert spacer 
molecule is incorporated between the sequence and the terminal modification. 
Microbeads used for aptamer selection were NHS-activated sepharose beads obtained 
from Bio-Rad laboratories. Microbeads used for bead-based PCR were Ultralink 
Streptavidin-coated beads obtained from Thermo Scientific Pierce Protein Research 
Products, Rockford, IL. Materials used in microfabrication included S1800 photoresist 
(Dow Chemical, Midland, MI), SU-8 2000 (Microchem, Newton MA), PDMS 
prepolymer (Dow Chemical), and Dix C Parylene prepolymer (Uniglobe Kisko, White 
Plains NY). PCR reagents included GoTaq Flexi PCR Mix (Promega, Madison WI), Taq 
enzyme (Promega), and deoxynucleotide triphosphates (dNTPs, Promega). 
 The reactants used for on-chip amplification of candidate aptamers consisted of 
the following: 5 PCR Buffer (2 μL), 25 mM MgCl2 (0.6 μL), 10 mM dNTPs (0.4 μL), 
50 μg/mL BSA (0.4 μL), microbeads (0.5 μL), water (5.6 μL), 25 μM forward primer 
(0.4 μL), and enzyme (0.1 μL). The reactants were degassed at -0.4 psi for 30 minutes in 
a darkened container prior to adding enzyme and proceeding with on-chip amplification. 
Reactants necessary for cloning and extraction of plasmid DNA are proprietary, and were 
purchased as part of the TOPO TA Cloning Kit and MiniPrep Extraction Kit from 
Invitrogen (Grand Island, NY). 
 
4-2.5 Experimental Protocol 
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 Prior to experimentation, the resistive temperature sensors were calibrated in an 
environmental chamber with a resistance temperature detector probe. Baseline 
temperature vs. resistance readings were also taken prior to every experiment. NHS-
activated microbeads were coated with IgE by washing them with 1 μM IgE 3× in a 
filtration column followed by incubation for 5 hours. Unbound ester molecules were then 
passivated by incubating the beads for 1 hour in Tris buffer. Following another wash in 
pure PBS, the beads were suspended and stored in PBS. Streptavidin-coated microbeads 
were coated with reverse primers by incubation with 1 μM dual-biotin labeled primers for 
30 minutes immediately prior to DNA capture. 
The temperature of the selection chamber was set to 37°C using closed-loop 
feedback programming in LabView and maintained during library incubation and 
removal of nonbinding oligomers. Having introduced the target-coated beads to the 
selection chamber and washed them with PBSM, three 30 μL samples of 10 μM library 
DNA (in PBSM) were flowed through the chamber at 5 μL/min, and each aliquot was 
retained following washing. Ten 30 μL samples of pure PBSM were then flowed through 
the chamber at 5 μL/min, and each was retained afterward for analysis. At this point, the 
amplification chamber was filled with reverse-primer coated microbeads. The selection 
chamber temperature was then set to 57°C, and four 30 μL samples of PBSM were 
introduced at 1 μL/min. These were subsequently directed to wash through the 
amplification chamber, over the reverse-primer coated microbeads.  Following each 30 
μL wash, the aliquot was retrieved and stored, PCR reagents were introduced to the 
amplification chamber, and the chamber temperature cycled to perform PCR 
amplification of the candidate aptamers directly onto the microbeads. Microbeads were 
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subsequently washed with PBS buffer and visualized using fluorescent microscopy to 
visualize surface DNA. Target ssDNA was then eluted by raising the chamber 
temperature to 95°C and flushing with pure PBSM. 
Fluorescent binding analysis was conducted using a selection chamber on a fresh 
microchip. Following device calibration, the chamber was filled with IgE-coated 
microbeads. Enriched library ssDNA was normalized to 1 μM concentration by 
measuring the concentration with UV/VIS spectroscopy and adding PBSM buffer. This 
sample was introduced to the chamber maintained at 37°C and fluorescence microscopy 
captured the fluorescent intensity of the microbeads. The experiment was repeated with 
random library also labeled with an identical fluorophore, purchased from IDT. 
Temperature-dependence of binding was measured in similar fashion, by incubating a 1 
μM concentration of enriched library with the microbeads and then continuously flowing 
PBSM at 2 μL/min while varying the chamber temperature. 
Cloning of enriched libraries was performed using the TOPO Cloning protocol, 
with plasmid DNA purified using the PureLink Quick protocol. Pools of enriched DNA 
were amplified using conventional PCR and unlabeled primer sequences for 25 cycles. 
Sequences were then cloned into the TOPO vector, and DNA sequences were harvested 
from E.coli and purified prior to sequencing. Sequencing was performed by the DNA 
Sequencing Lab at the Columbia University Protein Core Facility.  
  
4-3 Results and Discussion 
4-3.1 Physical Characterization of the Device 
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 Having fabricated the aptamer isolation chip, integrated temperature sensors were 
calibrated and the mixer and amplification chamber tested for functionality. The chip was 
placed in an environmental chamber and its temperature varied while the resistance of the 
temperature sensor was measured. From the linear relationship between temperature and 
resistance (Figure 4-3a), the temperature coefficient of resistance was measured, enabling 
future resistance measurements to be correlated to on-chip temperature. The on-chip 
mixer was designed to fully mix reagents with library DNA. As shown in Figure 4-3b, 
the mixer fully mixes a clear stream of buffer with a stream of green-dyed PCR reagents. 
The amplification chamber was tested for its ability to properly amplify DNA by 
performing bead-based PCR of a sample of library DNA. Bead-based microfluidic PCR 
in an integrated device has been previously characterized [158]. Sample loss and bubble 
generation were minimized by coating the chip with Parylene C and degassing reagents 
prior to temperature cycling. A labview digital PID controller was programmed to 
achieve and maintain setpoint temperatures by measuring the resistance of the on-chip 
resistive temperature sensor and apply voltage to the resistive heater. Fluorescent and 
UV/VIS microscopy confirmed the generation of product DNA using on-chip 
amplification.  
 
























































































Figure 4-3: Characterization of the microchip. In (a), the linear relationship between 
temperature and resistor resistance for the (i) selection chamber and (ii) PCR chamber 









, respectively. The passive mixer (b) fully mixes a 
stream of buffer and dye at 5 μL/min. 
 
4-3.2 Microfluidic Aptamer Isolation 
The operation of the microfluidic SELEX chip consists of two protocols: selection 
and amplification. The selection protocol serves to partition non-binding and weakly 
bound nucleic acids in the randomized library from the few oligomers which express 
temperature-dependent binding affinity to the target molecule. Initially, the entire library 
is incubated with the target-coated microbeads at the binding temperature, 37°C. 
Selection is then effected by maintaining the microchamber temperature and washing the 
microbeads with aliquots of pure buffer solution to elute undesired nucleic acids. As 
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samples of buffer were washed over the beads and recovered from the chip, each sample 
retained the unwanted nucleic acids. Samples of each buffer wash were amplified using 
PCR and visualized using slab-gel electrophoresis (Figure 4-4). As indicated by the 
intensity of the intercalating fluorescent dye, the concentration of DNA in each sample 
(identically amplified) decreases as the beads continue to be washed. This indicates that 
the wash steps removed more and more unbound DNA, presumably leaving only the 
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Figure 4-4. Gel electrophoresis of buffer samples containing weakly bound DNA washed 
away from target molecules during selection. The decreasing fluorescent intensity with 
continuing washes indicates that the selection process is removing weakly bound DNA, 
leaving strongly bound DNA to eventually be captured and amplified. 
 
Following removal of unwanted nucleic acids during selection, desired strands 
were eluted by raising the microchamber temperature to 57°C and again washing with 
pure buffer. This aliquot of buffer, containing DNA expressing temperature-dependent 
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binding affinity to IgE, was driven to the amplification chamber and incubated with 
primer-coated microbeads. There, the primers captured the DNA onto the microbeads 
where it was amplified via PCR. Confirmation of the elution-capture-amplification 
process was obtained by incorporation of a fluorescent label on the forward (in-solution) 
primers used during PCR. Following amplification, fluorescent bead intensity was 
monitored via fluorescent microscopy to confirm the generation of labeled dsDNA on the 
bead surfaces. This elution-capture-amplification procedure was completed four times to 
ensure that all desired IgE-binding nucleic acids were captured from the selection 
chamber. As shown in Figure 4-5, an analysis of the fluorescent bead intensity following 
25 cycles of amplification shows that DNA from the initial aliquot of buffer was 
successfully amplified onto the bead surfaces, but processing of further aliquots resulted 
in no detectable DNA. This indicates that not only did the process succeed in amplifying 
DNA, but that the elution-capture-amplification process efficiently captured the desired 
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Figure 4-5. Results from fluorescent analysis of bead-based PCR amplification of 
aptamer candidates. 
 
Following amplification, aptamer candidates were eluted as ssDNA into pure 
buffer solution and collected for further analysis. A 2 µL sample was amplified off-chip 
using unlabeled primers and cloned using the TOPO vector and E.coli. This process 
separated the many randomized strands into individual plasmids, each amplified by an 
individual bacterial colony. These colonies were harvested, cultured, and then subjected 
to DNA extraction. Twenty-four clones were chosen at random for sequencing, as shown 
in Table 3-1. A comparison of the sequences indicated that the library had not fully 
converged to a binding sequence. However, an alignment analysis indicated a 39 base 
region with 25-66% agreement among each base [159], a significant improvement from 
completely random data. Folding analysis of each clone showed the presence of 
secondary structures similar to those of a previous temperature-sensitive IgE-binding 
aptamer (Figure 4-6) [33]. 
 
 
Figure 4-6. Secondary structures of clones 12, 17, and 15. 
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Table 4-1. Results of sequencing the enriched library 
Clone ID Randomized Region
1 5' - TGT CCC ACA GAT GAA TTG GTC GAT GGG GAG TAA TTT GGG C - 3'
2 5' - GGG TCG TCT GAT TGA AGC ATG TAC AGC TTG TGA GCA TCC T - 3'
3 5' - GGG GGT GCG GGC GCC CGG GCG GCG GGC GTG GGG GAG GGC G - 3'
4 5' - GAG GGC GGT ACA GCT GAG GGG GGA CAA TGT AGT GGG GGT G - 3'
5 5' - TAC GAA CCA CGA TTT ACT TAT GCA TCG TGA TCG CGT ACA T - 3'
6 5' - GAC TTA GAC GTA GTG TTC ACA CGT CAG TAG TGT ATA CTG G - 3'
7 5' - GTC AGC TGC ATG AAC GAC CAC AAT TTT ATG GGC TGG TCG T - 3'
8 5' - TAT GTT CAT GAT TTA GTA AGT TTG ATT CAT CCG GAN GGT C - 3'
9 5' - TGG AAG ATG TGC GGG GAG CAT GGC GGG GCT TTC TAG GGT G - 3'
10 5' - GGG GGT GCG GGC GCC CGG GCG GCG GGC GTG GGG GAG GGC G - 3'
11 5' - TGA GTG TTA GCG GTA CCT TTG GGC TGC GGG AGG CGC GTC G - 3'
12 5' - GGC TTA CTC TCA TGT AGT TCC AAG GGC GAA TTC CAG CAC A - 3'
13 5' - AAA TGG CAC TGA ATC GAA CCC GAG AGG AAT CTC CTG TGC G - 3'
14 5' - CGG GGT ATG GCG GTG TCC TTT ACT GGG GGC CAT GAT GCG G - 3'
15 5' - CAA CAA TCT TTT TTG CAG TAC TTT GAA GGT TAA TAT GAG G - 3'
16 5' - GAC GTG GCA GCA TTA GTC TCG GGG TCT CAT GGG TGT TGG G - 3'
17 5' - TAA CGT ATC CTC ATA AGT GCC GGG CAA GTT TCT ACA CGT T - 3'
18 5' - GTT AGG AGC GTA GTA CTT GTG TGG GTG GGA GTG GCN TTC G - 3'
19 5' - CCA AGT TAG GGG ACA GGT GGG CGG CTG CCG GGG GGA GGG G - 3'
20 5' - ATC TTG AGC CGA GTC TTT AAG GGG CTG TGT TTG GCT TTT A - 3'
21 5' - CCC TTA CTT CAA TAA GTG GTA TAA AAC TGT TCT GCG CTA G - 3'
22 5' - GTA AAC TGT CAG ATT TAG AAT CGG CTT GAT GCC CGT ATA G - 3'
23 5' - GGC TTA CTC TCA TGT AGT TCC AAG GGC GAA TTC CAG CAC A - 3'
24 5' - TAG GGG GGG CGT GGG GAA GAG GGG CGT CGC GGG GGG GGG G - 3'
 
 
4-3.3 Binding Strength of Enriched Library 
Following testing of the device, binding of candidate aptamers were analyzed 
using a fluorescent assay in which purified, fluorescently labeled ssDNA is introduced to 
a microchamber filled with target-coated microbeads and maintained at 37°C. The 
fluorescent intensity of the microbeads, indicative of the surface concentration of bound 
DNA, was then measured following incubation and washing with buffer. As shown in 
Figure 7, the enriched library generated a larger fluorescent signal compared to the 
randomized library, indicating that the SELEX process increased the pool’s binding 
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affinity to IgE. Analysis of the fluorescent signals showed that the enriched library 






























































Figure 4-7. Analysis of DNA-IgE binding. IgE-coated microbeads were exposed to 
fluorescently labeled DNA, and the fluorescence intensity of the beads, indicative of the 
surface concentration of DNA, was measured. 
 
Following the binding analysis at 37°C, the temperature-dependence of the DNA-IgE 
binding was analyzed using a similar approach. A microchamber filled with fresh IgE-
coated microbeads was exposed to 1 µM enriched library DNA until the fluorescent 
signal saturated. Maintaining the chamber temperature at 37°C, fresh buffer was flowed 
through the chamber to ensure that binding equilibrium had been reached. The chamber 
temperature was then varied while flowing buffer solution, and the fluorescent intensity 
measured as a function of temperature. As shown in Figure 8, the concentration of 
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surface bound DNA varies strongly as a function of temperature, as intended by the 
temperature-specific selection. 
 





























Figure 4-8. Temperature-dependence of DNA-IgE binding. 
 
4-4 Conclusions 
Aptamers have applications in a wide variety of fields, but their use has been 
hindered by the long development times and significant costs associated with generating 
binding sequences. In an attempt to address this problem, an integrated microchip process 
has been developed for the isolation of target-binding sequences. The bead-based 
selection and amplification protocol successfully separates weakly binding nucleic acids 
from desired strongly bound aptamer candidates, and allows on-chip amplification and 
collection of target ssDNA. The chip-based aptamer isolation protocol was shown to 
enrich a randomized library of DNA for temperature-sensitive binding to IgE. After one 
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round of enrichment, the DNA library showed enhanced binding and partial consensus, 
with individual sequences approaching a binding motif. The selection and amplification 
required only 3 hours and approximately 5 microliters of PCR reagents, significantly 
lower requirements for a standard round of aptamer isolation. 
Previous attempts to improve aptamer isolation technology have included changes 
to selection protocols [2, 82], integration of selection and amplification [1, 87], and 
automation [70]. These efforts have in some cases reduced assay time or enhanced 
selection efficiency and effectiveness, but have generally failed to do both. A fully bead-
based protocol on a microfluidic chip has the potential to accomplish this goal, by using a 
highly effective separation method and integrating the selection and amplification 
processes in one chip.  
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Chapter 5: An Integrated Microfluidic SELEX Chip 
5-1 Introduction 
Aptamers are single-stranded nucleic acids which express binding affinity to 
molecular targets. Their molecular recognition abilities are based on conformation of the 
nucleotide sequence to the structure of the target molecule, which enable a combination 
of weak forces (ionic interactions, hydrogen bonds, hydrophobic interaction, and van der 
Waals) to together create a very tight, highly specific bond. The process by which 
aptamer sequences are developed is called SELEX, or Selective Evolution of Ligands by 
EXponential Enrichment. SELEX is traditionally an iterative process in which alternating 
cycles of selection and amplification drive the evolution of a randomized library of 
nucleic acid sequences towards a binding motif. 
As with most molecular biology protocols, SELEX is conventionally performed 
by pipetting samples between bench top instruments used for selection and amplification 
(typically via PCR, polymerase chain reaction). This approach to experimentation is 
necessarily slow and error-prone, due to the many individual steps required on the part of 
the experimenter. In addition, the underlying technologies employed for these steps have 
undergone significant improvements as SELEX has matured since its first use in 1989 
[40, 62]. Initial targets for SELEX were primarily proteins, and this in part led to 
nitrocellulose filter paper being employed as a partitioning medium for the selection step, 
as the negative charge of the nitrocellulose helped to attract DNA bound proteins which 
are typically positively charged [66]. Since then, a variety of techniques have been 
applied including both macroscale technology (such as agarose filter columns with 
covalently attached target molecules) to microscale partitioning methods like capillary 
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electrophoresis [72] and M-SELEX [2, 82]. As these techniques are more efficient, fewer 
SELEX rounds are now required to evolve a binding sequence. 
In addition to improvements in selection technology, automation of the SELEX 
process has improved process control. For example, robotic control of conventional 
SELEX resulted in a significant drop in the human resources required to perform the 
process [70]. This approach requires a large amount of startup capital, however. 
Alternatively, a SELEX device using microlines, pumps, and a connected PCR machine 
illustrated that integrated SELEX can potentially avoid manual pipetting steps by directly 
connecting equipment performing each necessary step of the process [1]. While the 
device was not fully successful, it illustrated that the “lab on a chip” approach to SELEX 
had great potential. 
By miniaturizing protocols such as SELEX, time and resources can be conserved 
via more efficient surface-based chemical reactions, owing largely to the much greater 
surface area to volume ratios characteristic of such designs. Recently, microfluidics has 
been applied to selection and integrated SELEX to generate vastly improved devices 
capable of producing aptamers in days rather than weeks or months. For example, while 
many previous approaches to SELEX have made use of microbeads for selection [70, 71], 
doing so in a microfluidic selection device is a relatively recent advance [2, 82]. Such 
microfluidic microbead-based selection devices are capable of vast reductions in assay 
time, by requiring only 1-3 rounds of SELEX instead of 10-20. Microfluidics also offers 
enhanced amplification and automation [79, 80, 157], and as such, can render highly 
efficient aptamer generation devices. In addition to microfluidic selection, integrated 
microfluidic SELEX devices have recently been demonstrated that incorporate bead-
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based selection with integrated amplification and collection of single-stranded DNA 
(ssDNA) [87, 88]. Such devices are capable of fully automated, rapid generation of 
aptamers. To date, however, an integrated microfluidic device with highly efficient 
selection (deriving aptamers in 1-3 rounds) has not been illustrated. 
We present an integrated microfluidic device which utilizes a bead-based PCR 
approach to integrate selection, amplification, and collection of ssDNA, generating 
aptamers which bind to target molecules at predetermined temperatures. The process 
requires far less time and reagents than conventional SELEX protocols, and successfully 
integrates highly-efficient microfluidic selection with amplification and collection of 
ssDNA. 
 
5-2 Principles and Design 
5-2.1 Design and Operation of the Microchip 
 Much of the principle of operation of this device is described in Chapter 4. Briefly, 
the device draws on a previously reported partitioning technique, making use of bead-
based selection to rapidly isolate target-binding nucleic acids from the randomized library. 
This approach has been augmented, however, with a bead-based PCR protocol which 
greatly simplifies the integration of SELEX on a microchip. Together they generate a 
rapid, efficient SELEX protocol capable of evolving aptamer sequences in 1 to 3 rounds 
of SELEX. The coupling of selection and amplification to generate a chip which rapidly 
isolates temperature-specific aptamers was discussed in Chapter 4. This chip essentially 
performed a single round of SELEX, accepting a randomized library and producing 
ssDNA enriched for temperature-specific binding affinity to human IgE. In this chapter, 
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this approach has been extended by designing a similar chip which can perform multiple 
rounds of SELEX and integrates a counter-selection step. 
 As shown in Figure 5-1, the integrated SELEX microchip consists of three 
primary chambers: selection, counter-selection, and amplification. As discussed in the 
previous chapter, microfluidic selection uses target-coated microbeads and integrated 
temperature control to partition strongly-bound aptamer candidates from unwanted 
weakly-bound ssDNA. In addition, a bead-based microfluidic PCR protocol is integrated 
to purify and amplify the desired aptamer candidates before elution into buffer 
(collection). In comparison to the previous chapter, this microchip is designed to perform 
multiple rounds of SELEX without intervention. Following amplification of the aptamer 
candidates in the integrated bead-based PCR microchamber, ssDNA can be eluted 
directly to the selection chamber for further rounds of SELEX. The design of the library, 
including primers modified for bead-based amplification and collection, is identical to 
that of the previous chapter. Changes to the design of the microchip include a more 
complex microfluidic channel network for directing flow to the microchambers, active 












Figure 5-1. Layout of Integrated SELEX Microchip. Drawn in red and highlighted with 
arrows are the microfluidic chambers for selection, counter-selection, and amplification. 
Blue lines indicate resistive heaters and sensors, and green lines show the placement of 
pneumatic lines for integrated active valves. 
 
Also shown in Figure 5-1 in green are pneumatic channels placed perpendicular to 
the fluidic channels. These channels are etched into the glass chip and separated from the 
fluidic channels by a thin elastomer membrane. Increasing the pressure in these channels 
via an off-chip source of compressed gas actuates the membrane, interrupting the flow of 
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sample and reagents in the fluidic microchannel. A sample cross-section of such a design 
is shown in Figure 5-2. Previous work has shown that this design produces highly 











Figure 5-2. Pneumatic channel design. 
 
Integrated counter-selection has been included in the chip design via a second 
selection chamber. The microbeads used for selection will be inserted into this chamber 
without target functionalization (the active NHS binding sites will be blocked with free 
primary amines using Tris buffer), and the chamber maintained at the binding 
temperature (still 37°C). To perform counter-selection against the beads, support 
molecules, and other unintended targets the DNA library will be incubated for 10 minutes 
in this chamber after 3 rounds of SELEX, prior to amplification. As a result, ssDNA that 
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 The materials used for the design, fabrication, and operation of the microfluidic 
SELEX chip are identical to those of the aptamer isolation chip discussed in Chapter 4. 
Human IgE was purchased from Athens Research, Athens, GA. All DNA was obtained in 
lyophilized form from Integrated DNA Technologies, Coralville, IA. The library is an 
80mer ssDNA oligomer consisting of a 40 base randomized region flanked by two 20 
base known priming regions. The purchased library sequence is as follows: 5’ – C TAC 
CTA CGA TCT GAC TAG CNN NNN NNN NNN NNN NNN NNN NNN NNN NNN 
NNN NNN NNN NNG CTT ACT CTC ATG TAG TTC C– 3’. The forward primers 
used were 5’ – C TAC CTA CGA TCT GAC TAG C – 3’, with or without a 5’ 
carboxyfluorescein modification. The reverse primers used were 5’ – G GAA CTA CAT 
GAG AGT AAG C – 3’, with a 5’ dual biotin attachment. In each case an inert spacer 
molecule is incorporated between the sequence and the terminal modification. 
Microbeads used for aptamer selection were NHS-activated sepharose beads obtained 
from Bio-Rad laboratories. Microbeads used for bead-based PCR were Ultralink 
Streptavidin-coated beads obtained from Thermo Scientific Pierce Protein Research 
Products, Rockford, IL. Materials used in microfabrication included S1800 photoresist 
(Dow Chemical, Midland, MI), SU-8 2000 (Microchem, Newton MA), PDMS 
prepolymer (Dow Chemical), and Dix C Parylene prepolymer (Uniglobe Kisko, White 
Plains NY). PCR reagents included GoTaq Flexi PCR Mix (Promega, Madison WI), Taq 
enzyme (Promega), and deoxynucleotide triphosphates (dNTPs, Promega). 
 The reactants used for on-chip amplification of candidate aptamers consisted of 
the following: 5 PCR Buffer (2 μL), 25 mM MgCl2 (0.6 μL), 10 mM dNTPs (0.4 μL), 
50 μg/mL BSA (0.4 μL), microbeads (0.5 μL), water (5.6 μL), 25 μM forward primer 
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(0.4 μL), and enzyme (0.1 μL). The reactants were degassed at -0.4 psi for 30 minutes in 
a darkened container prior to adding enzyme and proceeding with on-chip amplification. 
Reactants necessary for cloning and extraction of plasmid DNA are proprietary, and were 
purchased as part of the TOPO TA Cloning Kit and MiniPrep Extraction Kit from 
Invitrogen (Grand Island, NY). 
 
5-2.3 Experimental Protocol 
 Device characterization was performed as in the previous chapter.  Briefly, the 
resistive temperature sensor was calibrated in an environmental chamber. NHS beads 
were functionalized with IgE and then passivated with Tris buffer. Streptavidin-coated 
microbeads were incubated with primers for 30 minutes prior to bead-based PCR.  
 The primary selection protocol was performed identically to the previous chapter. 
Briefly, PBSM modified with 1 mM MgCl2 was used as the buffer for incubation of 
library DNA and elution of candidate aptamers. The binding and release temperatures, 
37°C and 57°C respectively, were maintained in the microchambers via closed-loop 
control using a LabView program. The counter-selection procedure was performed 
almost identically to the selection procedure: 1 mM PBSM containing the candidate 
aptamer pool was exposed to the microbeads at the binding temperature, which was 
maintained via closed-loop control.  In this case, this temperature was maintained while 
the candidate pool was washed through the chamber at 1 μL/min. This solution was then 
passed to the amplification chamber to undergo bead-based PCR. The amplification 
protocol and reagents were consistent with those of the previous chapter. In this case 
elution of ssDNA was followed by further rounds of SELEX (not final analysis). 
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However, sample ports in the microfluidic chip were used to obtain samples of the 
ssDNA pool following each round of SELEX. These samples were analyzed by cloning 
and sequencing to determine the evolution of the pool at each step of the SELEX process. 
Cloning and sequencing of the pools, as well as the fluorescent analysis of the individual 
sequences, were consistent with the approach used in the previous chapter. 
 
5-3 Initial Results and Ongoing Work 
 Multi-round microfluidic SELEX testing is currently underway. Currently, three 
pools of DNA are undergoing multiple rounds of SELEX to produce a temperature-
specific high-affinity aptamer specific to IgE. Thus far, results consist of DNA sequences 
from 5 different cloning and sequencing protocols. SELEX pools 1 and 2 have undergone 
2 rounds of SELEX each, and these sequences are prefixed 1-1, 1-2, 2-1, and 2-2, 
respectively. A third pool has undergone one round of SELEX, and the results are 
prefixed 3-1. The sequences are listed in Table 5-1 below. 
 



























































Ongoing work includes the analysis of the sequenced clones, as well as further 
rounds of SELEX.  It is anticipated that at least 3-4 rounds of SELEX will be needed to 
demonstrate full library evolution, and more than one selection approach is being 
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undertaken to both ensure evolution and to provide a basis for comparison of effects of 
flowrate and temperature on selection. Future data will include further sequencing results, 




This work will be concluded following the publication of this dissertation. 
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Chapter 6: Conclusions 
 
6-1 Dissertation Summary 
 Aptamers hold the potential to revolutionize a number of fields, including clinical 
diagnostics, therapeutics, and biological detection and separation. Molecules performing 
similar functions, such as monoclonal antibodies, are highly desired within these fields 
but are not as capable as their nucleic acid counterparts (see Introduction 1-2.1). The 
technology necessary to isolate target-binding aptamer sequences is available, but 
inadequate for the current demand (Introduction 1-3.1).  
 Recently, the application of microfluidics to SELEX has resulted in vast 
reductions in the amount of time necessary to generate binding sequences. Building on 
previous work, the goal of this dissertation was to generate microfluidic devices capable 
of generating high-affinity aptamer sequences in hours or days, rather than weeks or 
months as with conventional technology. In addition to building upon reported effective 
selection technology, this work implemented a new approach to integration of SELEX 
using a bead-based PCR technique, and took advantage of MEMS-based thermal control 
to generate aptamers with temperature-specific binding affinity. Specific results of this 
work include: 
 
6-1.1 A microfluidic cocaine aptasensor 
 The fabrication and testing of a microfluidic cocaine aptasensor. Cocaine-specific 
DNA aptamers were immobilized onto microbeads and trapped in a PDMS microfluidic 
chamber with weir structures above an integrated temperature sensor and heater. The 
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aptamers transduced cocaine binding via changes in fluorescent intensity, and results 
using fluorescent microscopy showed a linear response over 4 orders of magnitude of 
cocaine concentration, including physiologically relevant (nanomolar) concentrations. In 
addition, the ability of aptamer-functionalized surfaces to enrich target molecules allowed 
the device detection limit to be lowered to 10 pM following enrichment using continuous 
flow of a rarefied concentration of cocaine. Finally, using on-chip temperature control, 
the device was made fully reusable via thermal regeneration of the aptamer-coated 
surfaces. 
 
6-1.2 Integrated Microfluidic Bead-based PCR 
 A novel approach to integrated on-chip amplification was developed using bead-
based PCR. A method was developed whereby target DNA was captured by primer-
coated microbeads and amplified with fluorescently-labeled forward primers. In this way, 
the beads acted as a highly specific SPE surface, purifying the DNA from undesired ionic 
contamination and releasing the amplified DNA into a desired buffer solution. The 
incorporation of fluorescent labels transformed the amplification process into a detection 
scheme, by simultaneously concentrating the fluorescent labels on microbead surfaces 
enabling detection via fluorescent microscopy. It was demonstrated that the method was 
capable of detecting 1 pM DNA in only 10 cycles of amplification, and discerning this 
from a zero-template control (as determined by analysis of the data with the students’ t-
test). Furthermore, this process was integrated into a single temperature-controlled 
microchamber. It was demonstrated that a single microchamber with primer-coated 
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microbeads could capture, purify, amplify, detect, and release target DNA, potentially 
vastly simplifying an array of on-chip functions. 
 
6-1.3 Microfluidic Temperature-Specific Aptamer Isolation 
 A single round of selection/amplification was performed in an integrated 
microdevice and a randomized library was enriched for temperature-specific binding to 
human IgE. This device exploited on-chip temperature control to perform selection at 
pre-specified temperatures, directing the evolution of the library towards a binding motif 
with predetermined temperature-dependent binding properties. The bead-based 
amplification scheme was also incorporated to specifically capture, purify, amplify, and 
collect the target ssDNA. The device was designed to perform a single round of SELEX, 
demonstrating the capability of the designed selection/amplification schemes to work in 
concert to perform a highly efficient SELEX procedure. Fluorescence binding assays 
indicated that the enriched library expressed increased binding to IgE and that the binding 
strength exhibited the intended correlation with temperature. 
 
6-1.4 Ongoing Work on Integrated Microfluidic SELEX 
 In ongoing work, a fully integrated microfluidic device is being used to perform 
multiple rounds of temperature-specific SELEX. This device is capable of fully 
integrated, automated SELEX without the need for off-chip analysis or pipetting prior to 
collection of the fully enriched library. To demonstrate the effectiveness of the device, 3-
4 rounds of temperature-specific SELEX are being performed against IgE, and the 
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sequence pools are being cloned after each round to capture and analyze the evolution of 
the library towards a temperature-specific binding motif.  
 
6-2 Future Work 
 The devices demonstrated in this work represent proofs-of-concept, with several 
opportunities for subsequent applications and basic research.  
 
6-2.1 Bead-based microfluidic sensors 
 The microfluidic cocaine aptasensor described in Chapter 2 represents not only a 
cocaine sensor, but a platform for detection of a large number of analytes. As described 
in detail in this dissertation, the primary hindrance to the development of aptamer-based 
systems is the lack of aptamer sequences. There are already a significant number of 
aptamers targeting proteins and small molecules, however, and the bead-based sensing 
platform described herein is general to all such targets. While this work has focused on 
cocaine, substitution of any aptamer whose target falls into a similar molecular weight 
range should in principle be compatible. Of course sensor operation will necessarily vary 
based on the different binding characteristics of other aptamer-target systems 
(equilibrium dissociation constant, dissociation rate constants, etc.), but in principle 
similar results should be achievable. It should be noted that the cocaine-aptamer system 
used in this work possesses relatively weak binding, having an equilibrium dissociation 
constant of 1 µM and being based almost solely on hydrophobic interactions. As a result, 
the tighter binding associated with other aptamer-target systems may result in even lower 
detection limits when acting as a sensing system. 
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6-2.2 Integrated sample-to-answer devices using bead-based polymerase chain 
reaction  
As with the sensing platform described in Chapter 2, the bead-based PCR system 
has the potential to be used in a wide variety of applications. The primary utility of bead-
based PCR is that it can bridge incompatibilities between amplification and pre-
amplification steps such as differences in ionic, pH, or other buffer conditions. As such, 
protocols deriving nucleic acids from complex mixtures such as cell lysate for 
amplification and analysis have the potential to benefit from this protocol. Previous work 
has demonstrated that DNA-coated microbeads can be an effective SPE platform [133], 
and this dissertation has shown the power of integrating bead-based PCR with 
applications such as DNA detection and SELEX. Future applications for this technology 
include portable clinical diagnostic systems and integrated single-cell analysis of gene 
expression. 
 
6-2.3 Efficiency analysis of integrated microfluidic PCR 
The integrated multi-round SELEX device discussed in Chapter 5 must still be 
fully characterized. The ability of the device to converge a randomized library to a 
consensus binding sequence will be observed using both isothermal conditions and the 
temperature-specific selection protocol. The content of the randomized pools over several 
rounds of SELEX using both protocols may illustrate the effectiveness of the 
temperature-specific selection. Typical selection protocols maintain background 
conditions throughout selection to ensure that the generated binding sequence has high 
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affinity. In the temperature-specific approach, however, the background (i.e. temperature) 
conditions are varied, and this represents a second domain across which aptamers may be 
selected. The rate at which the library converges during selection to a binding motif may 
well vary between isothermal and temperature-specific methods, and this is of interest for 
further development of aptamer-generation devices. 
 
6-2.4 Temperature-specific SELEX against novel target molecules 
 The use of human IgE as a target molecule served to validate the developed 
aptamer isolation process, as there are already IgE-specific binding sequences available, 
including a temperature-specific aptamer which binds to IgE at 37°C and releases at 57°C 
[33]. Tailoring temperature-specificity in aptamer selection has not been well explored, 
and has great potential for aptamers developed for therapeutic applications. For example, 
some target proteins are expressed more strongly at higher temperatures, such as heat 
shock proteins. The ability to generate aptamers whose structure either folds in a 
temperature-dependent manner or whose binding is temperature-insensitive across a 
range of interest would be of great interest for therapeutic applications involving such 
proteins. When culturing cells, temperature control is paramount to ensure that cells 
remain viable and maintain consistent surface protein expression during selection. Cell-
SELEX, which is being widely explored for therapeutic purposes [161], would benefit 
greatly from a SELEX device which is capable of maintaining proper temperature control 
throughout the selection process. 
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6-2.5 Multiplexed SELEX for interrogation of binding schemes of synthetic nucleic 
acids 
Along with precise control over device features, microscale fabrication 
architecture affords the ability to scale up production and design to minimize costs or 
maximize yield. Following minor design changes, the microfluidic SELEX chips 
described in this dissertation could be adapted to work in tandem in a number of ways. 
An example application of such a multiplexed nucleic acid screening device would be to 
investigate the relationship between short DNA and RNA strands and enantiomeric 
microRNA (miRNA) sequences. MicroRNAs are short RNA sequences found in 
eukaryotic cells that act as post-transcriptional regulators [162]. For example, miRNA-
122 is a 74 nt miRNA found in liver cells, and is necessary for accumulation of hepatitis 
C virus (HCV) [163]. Inhibition of this miRNA with a locked nucleic acid complement 
was shown to suppress HCV in chimpanzees [164]. If the structural interactions between 
enantiomeric RNAs and their naturally structured DNA and RNA counterparts were well 
understood, enantiomeric RNA inhibitors for known miRNAs could be designed a priori 
without the need for screening binders using a SELEX-like process. 
 
6-3 Expected Developments and Final Words 
 Aptamer-generation devices and services are already coming online for 
commercial use; companies such as RiNA GmbH, AptSci, Custom Array, NeoVentures 
Biotechnology, LC Sciences, BasePair Biotechnology, and Aptagen offer or have offered 
customized aptamer generation for protein targets. These services are still very expensive, 
and they come without a guarantee of both high-affinity aptamers and a reasonable 
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development time. In the near future it is expected that these services will expand and 
their costs will be driven downward by both competition and advances in technology. 
The microfluidic “lab-on-a-chip” approach is ideally suited to minimizing aptamer 
generation time, by making the process more efficient through high surface area-to-
volume ratio surface-based selection and integrated, automated control of reaction 
conditions. 
For the great expectations of aptamer-based devices to come to fruition, a better, 
cheaper way of finding aptamer sequences must be found. The traditional model – of 
dedicated researchers using months of time and liters of expensive reagents to find a 
single binding sequence – is unsustainable if aptamers are to be seen as a true alternative 
to other molecular recognition species. While sequences found as a result of publicly 
funded research are available for use by all, aptamer development costs must be reduced 
if the profit-driven private sector is to be persuaded to develop aptamers for more useful 
targets. This work represents a proof-of-concept approach to aptamer sequence isolation 
that can be readily duplicated to provide aptamer sequences to both publicly- and 
privately-funded enterprises.  
  112 
  
Appendix 1: Supplementary Data for Bead-Based PCR 
 
A1-1 Bead-Based PCR Scheme 
Bead-based PCR is a solid-phase implementation of PCR, in which DNA is 
duplicated while tethered to the surfaces of microbeads in solution. In bead-based PCR, 
one of the two primer sets (typically the reverse primer) is tethered to a bead surface, 
while the untethered (forward) primer can be labeled with a detectable tag (e.g., a 
fluorophore). Bead-bound reverse primers are mixed with template ssDNA (Figure S1a), 
labeled forward primers and other reactants (e.g., nucleotides and Taq) in solution,and 
hybridize to template ssDNA molecules (Figure S1b). This results in the capture of 
template DNA by the microbeads and is hence effectively a SPE process. This completes 
the first temperature cycle, which produces unlabeled dsDNA (Figure S1c). During the 
second temperature cycle, the dsDNA from the previous cycle is denatured, allowing 
template DNA and fluorescently labeled forward primers to hybridize to bead-bound 
ssDNA (complementary strands of the template) (Figure S1d). Extension then generates 
labeled duplicates of template DNA hybridized to the bead-bound complementary strands 
(Figure S1e). This process is then repeated with further temperature cycles to produce 
exponentially increasing copies of dsDNA consisting of labeled template and unlabeled, 
bead-tethered complementary strands.  















Figure A1-1. DNA/Fluorescent Signal Generation. Primer-coated beads (a) hybridize to 
the DNA (b); an initial temperature cycle generates complementary ssDNA attached to 
the beads (c); during the following temperature cycle, fluorescently labeled primers are 
captured by the complementary ssDNA (d) and amplification generates fluorescently 
labeled dsDNA which remains attached to the beads (e). 
 
A1-2 Sensor Calibration 
Resistance measurements of a typical temperature sensor are shown in Figure S2, 
illustrating the linear relationship between resistance and temperature. This data was used 





























Figure A1-2. Calibration data for an integrated resistive temperature sensor.  
 
A1-3 Optimization of Magnesium Concentration.  
Optimum magnesium concentration was determined via a series of tests using 
different concentrations of MgCl2 in the reaction mixture. B. pertussis DNA templates 
were introduced to PCR reactions at a final concentration of 10 pM using the PCR 
mixture recipe described and PCR was performed for 20 cycles with an annealing 
temperature of 52°C in a commercial thermal cycler. Gel electrophoresis of the amplified 
samples indicated that a concentration of 1.5 mM MgCl2 produced the greatest amount of 
output DNA (data not shown), which is consistent with typical MgCl2 concentrations for 
PCR studies. This result is expected to be sequence-dependent, and thus particular to this 
example and not general to bead-based PCR. 
 
A1-4 Study of Optimum Dwell Time 
Dwell times, the length of time the PCR sample is incubated at each temperature during 
each PCR cycle, were optimized to produce the maximum amount of DNA within the 
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shortest reaction time possible. An optimum dwell time exists for solution-based PCR 
such that a larger time results in a minimal increase, or possibly a decrease, in reaction 
efficiency. To investigate the effect of dwell time on the bead-based PCR device, PCR 
reactions were performed for 20 cycles using different dwell times (data not shown). The 
results of the testing indicate that a 20 s dwell time most efficiently produces output DNA. 
This is consistent with typical dwell time values for microscale PCR devices, which 
typically enable shorter dwell times than conventional PCR cyclers due to more rapid and 
uniform sample heating.  
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